Interaction	O
between	O
NF-kappa	B-protein
B	I-protein
-and	O
serum	B-protein
response	I-protein
factor	I-protein
-binding	O
elements	O
activates	O
an	O
interleukin-2	B-DNA
receptor	I-DNA
alpha-chain	I-DNA
enhancer	I-DNA
specifically	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

We	O
find	O
that	O
a	O
short	O
enhancer	O
element	O
containing	O
the	O
NF-kappa	B-DNA
B	I-DNA
binding	I-DNA
site	I-DNA
from	O
the	O
interleukin-2	B-DNA
receptor	I-DNA
alpha-chain	I-DNA
gene	I-DNA
(	O
IL-2R	B-protein
alpha	I-protein
)	O
is	O
preferentially	O
activated	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

The	O
IL-2R	B-protein
alpha	I-protein
enhancer	O
binds	O
NF-kappa	B-protein
B	I-protein
poorly	O
and	O
is	O
only	O
weakly	O
activated	O
by	O
the	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
alone	O
.	O

Serum	B-protein
response	I-protein
factor	I-protein
(	O
SRF	B-protein
)	O
binds	O
to	O
a	O
site	O
adjacent	O
to	O
the	O
NF-kappa	B-DNA
B	I-DNA
site	I-DNA
in	O
the	O
IL-2R	B-DNA
enhancer	I-DNA
,	O
and	O
both	O
sites	O
together	O
have	O
strong	O
transcriptional	O
activity	O
specifically	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Surprisingly	O
,	O
the	O
levels	O
of	O
SRF	B-protein
constitutively	O
expressed	O
in	O
T	B-cell_type
cells	I-cell_type
are	O
consistently	O
higher	O
than	O
in	O
other	O
cell	O
types	O
.	O

Overexpression	O
of	O
SRF	B-protein
in	O
B	B-cell_type
cells	I-cell_type
causes	O
the	O
IL-2R	B-DNA
enhancer	I-DNA
to	O
function	O
as	O
well	O
as	O
it	O
does	O
in	O
T	B-cell_type
cells	I-cell_type
,	O
suggesting	O
that	O
the	O
high	O
level	O
of	O
SRF	B-protein
binding	O
in	O
T	B-cell_type
cells	I-cell_type
is	O
functionally	O
important	O
.	O

MorEcuLtar	NULL
anp	NULL
CELLULAR	NULL
BroLooy	NULL
,	NULL
Apr	NULL
.	NULL

1993	NULL
,	NULL
p.	NULL
2536-2545	NULL
0270-7306/93/042536-10	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

4	NULL
Interaction	NULL
Between	NULL
NF-	NULL
«	NULL
B-	NULL
and	NULL
Serum	NULL
Response	NULL
Factor-Binding	NULL
Elements	NULL
Activates	NULL
an	NULL
Interleukin-2	NULL
Receptor	NULL
«	NULL
-Chain	NULL
Enhancer	NULL
Specifically	NULL
in	NULL
T	NULL
Lymphocytes	NULL
ANNA	NULL
A.	NULL
KUANG	NULL
,	NULL
t	NULL
KRISTINE	NULL
D.	NULL
NOVAK	NULL
,	NULL
#	NULL
SANG-MO	NULL
KANG	NULL
,	NULL
§	NULL
KEVIN	NULL
BRUHN	NULL
,	NULL
AND	NULL
MICHAEL	NULL
J.	NULL
LENARDO*	NULL
Laboratory	NULL
of	NULL
Immunology	NULL
,	NULL
Room	NULL
11D09	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
Received	NULL
6	NULL
November	NULL
1992/Returned	NULL
for	NULL
modification	NULL
18	NULL
December	NULL
1992/Accepted	NULL
6	NULL
January	NULL
1993	NULL
We	NULL
find	NULL
that	NULL
a	NULL
short	NULL
enhancer	NULL
element	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
(	NULL
IL-2Ra	NULL
«	NULL
)	NULL
is	NULL
preferentially	NULL
activated	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
IL-2Ra	NULL
enhancer	NULL
binds	NULL
NF-	NULL
«	NULL
B	NULL
poorly	NULL
and	NULL
is	NULL
only	NULL
weakly	NULL
activated	NULL
by	NULL
the	NULL
NF-B	NULL
site	NULL
alone	NULL
.	NULL

Serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
binds	NULL
to	NULL
a	NULL
site	NULL
adjacent	NULL
to	NULL
the	NULL
NF-B	NULL
site	NULL
in	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
,	NULL
and	NULL
both	NULL
sites	NULL
together	NULL
have	NULL
strong	NULL
transcriptional	NULL
activity	NULL
specifically	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Surprisingly	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
SRF	NULL
constitutively	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
consistently	NULL
higher	NULL
than	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

Overexpression	NULL
of	NULL
SRF	NULL
in	NULL
B	NULL
cells	NULL
causes	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
to	NULL
function	NULL
as	NULL
well	NULL
as	NULL
it	NULL
does	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
high	NULL
level	NULL
of	NULL
SRF	NULL
binding	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
functionally	NULL
important	NULL
.	NULL

The	NULL
a-chain	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
(	NULL
IL-Z2Ra	NULL
)	NULL
is	NULL
a	NULL
key	NULL
surface	NULL
protein	NULL
that	NULL
is	NULL
expressed	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
is	NULL
a	NULL
major	NULL
regulator	NULL
of	NULL
T-cell	NULL
proliferation	NULL
and	NULL
death	NULL
(	NULL
23	NULL
,	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

The	NULL
IL-Z2Ra	NULL
protein	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
high-affinity	NULL
receptor	NULL
for	NULL
IL-2	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
receptor	NULL
is	NULL
expressed	NULL
early	NULL
in	NULL
mouse	NULL
T-cell	NULL
differentiation	NULL
on	NULL
CD4~	NULL
CD8~	NULL
thymocytes	NULL
,	NULL
in	NULL
which	NULL
it	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
expansion	NULL
of	NULL
thymocyte	NULL
number	NULL
(	NULL
58	NULL
)	NULL
.	NULL

The	NULL
IL-2Ra	NULL
«	NULL
protein	NULL
,	NULL
and	NULL
presumably	NULL
its	NULL
gene	NULL
,	NULL
are	NULL
turned	NULL
off	NULL
at	NULL
later	NULL
stages	NULL
of	NULL
thymic	NULL
development	NULL
.	NULL

In	NULL
mature	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
can	NULL
be	NULL
reexpressed	NULL
following	NULL
antigen	NULL
stimulation	NULL
.	NULL

This	NULL
is	NULL
a	NULL
tightly	NULL
regulated	NULL
process-resting	NULL
T	NULL
lymphocytes	NULL
express	NULL
virtually	NULL
no	NULL
IL-Z2Ra	NULL
«	NULL
,	NULL
whereas	NULL
antigen-acti-vated	NULL
T	NULL
cells	NULL
have	NULL
surface	NULL
expression	NULL
of	NULL
3	NULL
x	NULL
10°	NULL
to	NULL
6	NULL
x	NULL
10*	NULL
IL-2Ra	NULL
molecules	NULL
(	NULL
62	NULL
)	NULL
.	NULL

The	NULL
IL-2Ra	NULL
gene	NULL
is	NULL
most	NULL
commonly	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
can	NULL
be	NULL
expressed	NULL
also	NULL
in	NULL
other	NULL
hematopoietic	NULL
cells	NULL
(	NULL
62	NULL
)	NULL
.	NULL

During	NULL
antigen	NULL
activation	NULL
of	NULL
mature	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
DNA	NULL
sequence	NULL
that	NULL
binds	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
complex	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
27	NULL
,	NULL
44	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
protein	NULL
complex	NULL
that	NULL
enables	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
to	NULL
be	NULL
rapidly	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
extracellular	NULL
stimuli	NULL
(	NULL
16	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Two	NULL
polypeptides	NULL
,	NULL
termed	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
together	NULL
form	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
transactivator	NULL
by	NULL
specifically	NULL
binding	NULL
to	NULL
a	NULL
10-nucleotide	NULL
DNA	NULL
sequence	NULL
(	NULL
2	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
recent	NULL
cloning	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
reveals	NULL
that	NULL
they	NULL
belong	NULL
to	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
DNA-binding	NULL
protein	NULL
genes	NULL
,	NULL
which	NULL
includes	NULL
p50	NULL
,	NULL
p49/p50B	NULL
(	NULL
lyt-10	NULL
)	NULL
,	NULL
p65	NULL
,	NULL
c-re/	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
v-rel	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
21	NULL
,	NULL
34	NULL
,	NULL
35	NULL
,	NULL
45	NULL
,	NULL
49	NULL
,	NULL
50	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Mature	NULL
B	NULL
cells	NULL
express	NULL
high	NULL
constitutive	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
p50/p6S5	NULL
het-erodimer	NULL
)	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Most	NULL
other	NULL
cells	NULL
contain	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
a	NULL
non-DNA-binding	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
complexed	NULL
with	NULL
an	NULL
inhibitory	NULL
protein	NULL
called	NULL
I-	NULL
«	NULL
B	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

{	NULL
Present	NULL
address	NULL
:	NULL
Cornell	NULL
University	NULL
Medical	NULL
College	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

+	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Duke	NULL
University	NULL
,	NULL
Durham	NULL
,	NULL
NC	NULL
.	NULL

§	NULL
Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
.	NULL

2536	NULL
that	NULL
prevents	NULL
both	NULL
nuclear	NULL
translocation	NULL
and	NULL
DNA	NULL
binding	NULL
(	NULL
2	NULL
)	NULL
.	NULL

-B	NULL
belongs	NULL
to	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
sharing	NULL
a	NULL
conserved	NULL
protein	NULL
motif	NULL
known	NULL
as	NULL
the	NULL
ankyrin	NULL
repeat	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
17	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
can	NULL
be	NULL
released	NULL
from	NULL
IB	NULL
and	NULL
become	NULL
active	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
T	NULL
cells	NULL
following	NULL
stimulation	NULL
of	NULL
the	NULL
antigen	NULL
receptor	NULL
with	NULL
antigen	NULL
or	NULL
surrogate	NULL
stimuli	NULL
(	NULL
19	NULL
,	NULL
20	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
lymphoid	NULL
lineage	NULL
,	NULL
it	NULL
is	NULL
largely	NULL
unknown	NULL
what	NULL
additional	NULL
molecular	NULL
determinants	NULL
cause	NULL
specific	NULL
genes	NULL
to	NULL
respond	NULL
to	NULL
NF-kB	NULL
and	NULL
related	NULL
activators	NULL
in	NULL
T	NULL
cells	NULL
versus	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
«	NULL
gene	NULL
(	NULL
x	NULL
)	NULL
and	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
26	NULL
,	NULL
27	NULL
,	NULL
44	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
c-re/	NULL
can	NULL
bind	NULL
to	NULL
and	NULL
presumably	NULL
transactivate	NULL
the	NULL
IL-2R	NULL
B	NULL
site	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
27	NULL
,	NULL
44	NULL
,	NULL
57	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
the	NULL
kB	NULL
site	NULL
from	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
caused	NULL
greater	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
that	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
preferential	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
facilitated	NULL
by	NULL
an	NULL
adjacent	NULL
site	NULL
in	NULL
the	NULL
IL-ZRa	NULL
«	NULL
oligonucleotide	NULL
that	NULL
binds	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
.	NULL

SRF	NULL
mediates	NULL
both	NULL
growth	NULL
factor	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
and	NULL
muscle	NULL
actin	NULL
gene	NULL
regulation	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
32	NULL
,	NULL
36	NULL
,	NULL
41	NULL
,	NULL
42	NULL
,	NULL
46	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Growth	NULL
factor	NULL
or	NULL
protein	NULL
kinase	NULL
C	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
apparently	NULL
may	NULL
not	NULL
alter	NULL
the	NULL
levels	NULL
of	NULL
SRF	NULL
binding	NULL
but	NULL
possibly	NULL
alters	NULL
a	NULL
constitutively	NULL
bound	NULL
SRF	NULL
complex	NULL
with	NULL
its	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
or	NULL
causes	NULL
additional	NULL
protein	NULL
interactions	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
18	NULL
,	NULL
43	NULL
,	NULL
46	NULL
,	NULL
56	NULL
)	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
that	NULL
elevated	NULL
levels	NULL
of	NULL
SRF	NULL
binding	NULL
activity	NULL
in	NULL
T-lymphoid	NULL
cells	NULL
are	NULL
important	NULL
for	NULL
regulating	NULL
an	NULL
SRE-like	NULL
sequence	NULL
in	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
SRF-	NULL
and	NULL
NF-	NULL
«	NULL
B-binding	NULL
elements	NULL
together	NULL
cause	NULL
preferential	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
transfection	NULL
.	NULL

MT-2	NULL
,	NULL
EL4	NULL
,	NULL
$	NULL
194	NULL
,	NULL
P3X63AG8	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
(	NULL
Biofluids	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
500	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
50	NULL
M	NULL
B-mercaptoethanol	NULL
.	NULL

DEAE	NULL
transfections	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
stimulations	NULL
,	NULL
and	NULL
analysis	NULL
of	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
x	NULL
CACACCSCACTTTCCGACASSC	NULL
ILR	NULL
(	NULL
-268	NULL
to	NULL
-243	NULL
)	NULL
sIL2R	NULL
GCoGAATCTCCC	NULL
ILT	NULL
ereoocrorcopppanescccer	NULL
MALT	NULL
sre	NULL
CCTTATCAAACATCCCOATATATCGGCATCTTCTGCAGCA	NULL
IL2R-m1	NULL
_	NULL
IL2R-m2	NULL
_	NULL
RAA	NULL
Tac	NULL
IL2R-m3	NULL
.	NULL

GeecaaTcrooctoammaaATiatesc	NULL
IL2R-m5	NULL
.	NULL

geecaaperoocrencoppeseg	NULL
@	NULL
e	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

DNA	NULL
sequences	NULL
of	NULL
the	NULL
mouse	NULL
immunoglobulin	NULL
k	NULL
and	NULL
human	NULL
IL-2R	NULL
«	NULL
oligonucleotides	NULL
.	NULL

Only	NULL
the	NULL
top	NULL
strands	NULL
are	NULL
depicted	NULL
.	NULL

The	NULL
x	NULL
oligonucleotide	NULL
was	NULL
defined	NULL
by	NULL
Pierce	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
and	NULL
used	NULL
in	NULL
the	NULL
previous	NULL
study	NULL
(	NULL
8	NULL
)	NULL
.	NULL

IL-2R	NULL
is	NULL
the	NULL
enhancer	NULL
sequence	NULL
from	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
positions	NULL
-268	NULL
to	NULL
~243	NULL
)	NULL
used	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

sIL-2R	NULL
contains	NULL
only	NULL
the	NULL
NF-KB	NULL
binding	NULL
site	NULL
.	NULL

ILT	NULL
is	NULL
the	NULL
region	NULL
3	NULL
'	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
IL2R	NULL
oligonucleotide	NULL
that	NULL
contains	NULL
a	NULL
CArG	NULL
box	NULL
,	NULL
and	NULL
M-ILT	NULL
is	NULL
a	NULL
mutant	NULL
version	NULL
.	NULL

Not	NULL
shown	NULL
are	NULL
TCGA	NULL
extensions	NULL
on	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
all	NULL
oligonucleotides	NULL
used	NULL
for	NULL
cloning	NULL
.	NULL

SRE	NULL
is	NULL
from	NULL
the	NULL
Xenopus	NULL
y-actin	NULL
gene	NULL
that	NULL
binds	NULL
SRF	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
R.	NULL
Prywes	NULL
)	NULL
.	NULL

Singly	NULL
underlined	NULL
sequences	NULL
are	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
,	NULL
while	NULL
the	NULL
double-underlined	NULL
sequences	NULL
are	NULL
SRF	NULL
binding	NULL
sites	NULL
.	NULL

Boldface	NULL
type	NULL
indicates	NULL
point	NULL
mutations	NULL
in	NULL
these	NULL
sequences	NULL
.	NULL

activity	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Pierce	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

$	NULL
194	NULL
and	NULL
P3X63AG8	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
.	NULL

MT-2	NULL
and	NULL
ELA	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electro-poration	NULL
with	NULL
a	NULL
Bio-Rad	NULL
Gene	NULL
Pulser	NULL
apparatus	NULL
with	NULL
each	NULL
sample	NULL
containing	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
assay	NULL
in	NULL
0.25	NULL
ml	NULL
of	NULL
RPMI	NULL
plus	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

Samples	NULL
were	NULL
electroporated	NULL
at	NULL
200	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
capacitance	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
replated	NULL
at	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
of	NULL
RPMI	NULL
plus	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
stimulated	NULL
EL-4	NULL
plus	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
and	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Samples	NULL
were	NULL
normalized	NULL
according	NULL
to	NULL
protein	NULL
content	NULL
.	NULL

Thin-layer	NULL
chromatographic	NULL
plates	NULL
were	NULL
counted	NULL
in	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
Phospho	NULL
Imager	NULL
.	NULL

The	NULL
percent	NULL
acetylation	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
sum	NULL
of	NULL
the	NULL
acetylated	NULL
and	NULL
diace-tylated	NULL
values	NULL
by	NULL
the	NULL
total	NULL
of	NULL
each	NULL
sample	NULL
.	NULL

Plasmid	NULL
constructions	NULL
.	NULL

CAT	NULL
reporter	NULL
plasmids	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
A56-c-fos	NULL
CAT	NULL
plasmid	NULL
(	NULL
13	NULL
)	NULL
or	NULL
the	NULL
pBLCAT2	NULL
plasmid	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
A5S6-c-fos	NULL
CAT	NULL
backbone	NULL
is	NULL
truncated	NULL
so	NULL
as	NULL
to	NULL
eliminate	NULL
most	NULL
known	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
the	NULL
SRE	NULL
,	NULL
leaving	NULL
only	NULL
the	NULL
TATA	NULL
motif	NULL
and	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
with	NULL
sequences	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Inc.	NULL
,	NULL
model	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
and	NULL
were	NULL
kinased	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
unique	NULL
Sa/Zl	NULL
sites	NULL
in	NULL
either	NULL
A56-c-fos	NULL
CAT	NULL
or	NULL
PBLCAT2	NULL
,	NULL
as	NULL
carried	NULL
out	NULL
previously	NULL
(	NULL
26	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Not	NULL
depicted	NULL
in	NULL
the	NULL
sequences	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
are	NULL
5'-TCGA-3	NULL
'	NULL
extensions	NULL
on	NULL
both	NULL
strands	NULL
that	NULL
allow	NULL
cloning	NULL
into	NULL
restriction	NULL
sites	NULL
(	NULL
SaZl	NULL
,	NULL
Xhol	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

that	NULL
are	NULL
compatible	NULL
.	NULL

To	NULL
create	NULL
an	NULL
SRF	NULL
expression	NULL
plasmid	NULL
,	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
human	NULL
SRF	NULL
cDNA	NULL
was	NULL
obtained	NULL
from	NULL
R.	NULL
Treisman	NULL
(	NULL
36	NULL
)	NULL
and	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
.	NULL

The	NULL
3.5-kb	NULL
SRF	NULL
cDNA	NULL
IL-2R	NULL
«	NULL
GENE	NULL
REGULATION	NULL
2537	NULL
fragment	NULL
was	NULL
filled	NULL
in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
Boehringer-Mannheim	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pBK28	NULL
obtained	NULL
from	NULL
I.	NULL
Verma	NULL
(	NULL
48	NULL
)	NULL
contains	NULL
a	NULL
FBJ-murine	NULL
sarcoma	NULL
virus	NULL
(	NULL
MSV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
addition	NULL
site	NULL
,	NULL
and	NULL
an	NULL
ampicillin	NULL
resistance	NULL
gene	NULL
.	NULL

pBK28	NULL
was	NULL
digested	NULL
with	NULL
Xhol	NULL
and	NULL
EcoRI	NULL
,	NULL
yielding	NULL
a	NULL
3.8-kb	NULL
fragment	NULL
that	NULL
was	NULL
filled	NULL
in	NULL
with	NULL
Klenow	NULL
,	NULL
treated	NULL
with	NULL
alkaline	NULL
phos-phatase	NULL
from	NULL
calf	NULL
intestine	NULL
(	NULL
Boehringer-Mannheim	NULL
)	NULL
,	NULL
and	NULL
then	NULL
ligated	NULL
to	NULL
the	NULL
3.5-kb	NULL
SRF	NULL
cDNA	NULL
fragment	NULL
.	NULL

The	NULL
EcoRI	NULL
SRF	NULL
fragment	NULL
was	NULL
also	NULL
cloned	NULL
directly	NULL
into	NULL
the	NULL
pMT2T	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
expression	NULL
plasmid	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Procedures	NULL
were	NULL
carried	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
or	NULL
standard	NULL
techniques	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
constructions	NULL
were	NULL
verified	NULL
by	NULL
restriction	NULL
endonuclease	NULL
mapping	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
with	NULL
modifications	NULL
that	NULL
we	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Binding	NULL
assays	NULL
were	NULL
either	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
25	NULL
)	NULL
or	NULL
modified	NULL
to	NULL
run	NULL
on	NULL
custom-made	NULL
minigel	NULL
apparatuses	NULL
(	NULL
Owl	NULL
Scientific	NULL
Co.	NULL
)	NULL
.	NULL

The	NULL
modified	NULL
reaction	NULL
was	NULL
in	NULL
6-	NULL
to	NULL
10-pl	NULL
total	NULL
volume	NULL
set	NULL
up	NULL
in	NULL
the	NULL
wells	NULL
of	NULL
a	NULL
Terasaki	NULL
plate	NULL
(	NULL
Nunc	NULL
Intermed	NULL
)	NULL
and	NULL
contained	NULL
2	NULL
to	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
protein	NULL
,	NULL
0.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
unless	NULL
otherwise	NULL
noted	NULL
,	NULL
and	NULL
40,000	NULL
cpm	NULL
(	NULL
Cerenkov	NULL
)	NULL
of	NULL
radiolabelled	NULL
target	NULL
DNA	NULL
in	NULL
a	NULL
solution	NULL
of	NULL
10	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
and	NULL
loaded	NULL
with	NULL
a	NULL
tapered	NULL
micropipette	NULL
tip	NULL
into	NULL
the	NULL
wells	NULL
of	NULL
the	NULL
minigel	NULL
apparatus	NULL
.	NULL

For	NULL
competitions	NULL
,	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
unlabelled	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
mix	NULL
,	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
protein	NULL
added	NULL
last	NULL
.	NULL

For	NULL
supershift	NULL
assays	NULL
,	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
with	NULL
either	NULL
preimmune	NULL
serum	NULL
or	NULL
anti-SRF	NULL
antiserum	NULL
(	NULL
RP-4	NULL
,	NULL
a	NULL
gift	NULL
of	NULL
R.	NULL
Prywes	NULL
)	NULL
against	NULL
a	NULL
C-terminal	NULL
peptide	NULL
of	NULL
SRF	NULL
.	NULL

Electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
30:1	NULL
)	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
380	NULL
mM	NULL
glycine	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
8.5	NULL
[	NULL
55	NULL
]	NULL
)	NULL
or	NULL
6.7	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
3.3	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
26	NULL
)	NULL
with	NULL
recirculation	NULL
of	NULL
the	NULL
buffer	NULL
at	NULL
a	NULL
voltage	NULL
of	NULL
11	NULL
V/cm	NULL
for	NULL
90	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

IxB	NULL
inhibition	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
preincubating	NULL
nuclear	NULL
extracts	NULL
with	NULL
bacterially	NULL
expressed	NULL
IB	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
A.	NULL
Baldwin	NULL
)	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
.	NULL

Aliquots	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
suspended	NULL
in	NULL
sorter	NULL
buffer	NULL
containing	NULL
1x	NULL
PBS	NULL
(	NULL
0.8	NULL
mM	NULL
potassium	NULL
phosphate	NULL
,	NULL
154	NULL
mM	NULL
sodium	NULL
chloride	NULL
,	NULL
2.9	NULL
mM	NULL
sodium	NULL
phosphate	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
)	NULL
with	NULL
2.5	NULL
%	NULL
FCS	NULL
and	NULL
0.1	NULL
%	NULL
sodium	NULL
azide	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
either	NULL
a	NULL
1:50	NULL
dilution	NULL
of	NULL
monoclonal	NULL
antibody	NULL
rat	NULL
immunoglobulin	NULL
M	NULL
7D4	NULL
against	NULL
the	NULL
mouse	NULL
IL-2Ra	NULL
«	NULL
chain	NULL
(	NULL
31	NULL
)	NULL
or	NULL
mouse	NULL
immunoglobulin	NULL
G2a	NULL
anti-Tac	NULL
against	NULL
the	NULL
human	NULL
IL-2Ra	NULL
chain	NULL
(	NULL
61	NULL
)	NULL
followed	NULL
by	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
mouse	NULL
anti-rat	NULL
k	NULL
or	NULL
goat	NULL
anti-mouse	NULL
immunoglobulin	NULL
G2a	NULL
(	NULL
Southern	NULL
Biotechnol-ogy	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Samples	NULL
of	NULL
10	NULL
``	NULL
events	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
Becton-Dickinson	NULL
FACSCAN	NULL
cytometer	NULL
with	NULL
Consort-30	NULL
software	NULL
.	NULL

RESULTS	NULL
Functional	NULL
differences	NULL
in	NULL
«	NULL
B	NULL
binding	NULL
oligonucleotides	NULL
.	NULL

Previously	NULL
it	NULL
was	NULL
found	NULL
that	NULL
a	NULL
22-base	NULL
oligonucleotide	NULL
bearing	NULL
the	NULL
immunoglobulin	NULL
x	NULL
light	NULL
chain	NULL
gene	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
x	NULL
)	NULL
acts	NULL
as	NULL
a	NULL
enhancer	NULL
in	NULL
both	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
,	NULL
whereas	NULL
a	NULL
26-base	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
oligonucleotide	NULL
from	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
promoter	NULL
functioned	NULL
preferentially	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
40	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
difference	NULL
,	NULL
we	NULL
prepared	NULL
new	NULL
test	NULL
constructs	NULL
with	NULL
single	NULL
copies	NULL
of	NULL
both	NULL
NF-KB	NULL
oligonucleotides	NULL
as	NULL
en-	NULL
2538	NULL
KUANG	NULL
ET	NULL
AL	NULL
.	NULL

Y=	NULL
t	NULL
at	NULL
A	NULL
I	NULL
vector	NULL
5	NULL
M	NULL
kappa	NULL
<	NULL
§	NULL
in	NULL
=	NULL
sll	NULL
2R	NULL
<	NULL
O	NULL
L	NULL
2	NULL
|	NULL
--	NULL
<	NULL
far	NULL
C	NULL
[	NULL
a	NULL
at	NULL
P3X63AG8	NULL
20	NULL
>	NULL
-|	NULL
an	NULL
2	NULL
B	NULL
I	NULL
vector	NULL
<	NULL
I	NULL
kappa	NULL
-	NULL
§	NULL
ilar	NULL
§	NULL
.	NULL

slL2R	NULL
LW	NULL
fess	NULL
<	NULL
«	NULL
1	NULL
td	NULL
C	NULL
o	NULL
%	NULL
p	NULL
EL-4	NULL
unstim	NULL
.	NULL

EL-4	NULL
stim	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

B1or..	NULL
W	NULL
vector	NULL
I	NULL
kappa	NULL
§	NULL
Lr	NULL
sIL2R	NULL
RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
$	NULL
194	NULL
504	NULL
I	NULL
vector	NULL
w|	NULL
-	NULL
B	NULL
koppa	NULL
§	NULL
in	NULL
slL2R	NULL
304	NULL
204	NULL
RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
MT-2	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
and	NULL
immunoglobulin	NULL
x	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

Relative	NULL
bacterial	NULL
CAT	NULL
activity	NULL
from	NULL
cell	NULL
lines	NULL
transfected	NULL
with	NULL
the	NULL
vector	NULL
alone	NULL
,	NULL
x-CAT	NULL
,	NULL
IL-ZR-CAT	NULL
,	NULL
or	NULL
sIL-2R-CAT	NULL
constructs	NULL
.	NULL

P3X63Ag8	NULL
and	NULL
$	NULL
194	NULL
are	NULL
murine	NULL
B-cell	NULL
lines	NULL
.	NULL

MT-2	NULL
is	NULL
a	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-infected	NULL
T-cell	NULL
line	NULL
,	NULL
and	NULL
EL-4	NULL
is	NULL
a	NULL
mouse	NULL
T-lymphoma	NULL
line	NULL
.	NULL

EL-4	NULL
transfections	NULL
were	NULL
divided	NULL
,	NULL
and	NULL
one	NULL
half	NULL
was	NULL
stimulated	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
to	NULL
induce	NULL
NF-kB	NULL
.	NULL

sIL-2R	NULL
contains	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Thin-layer	NULL
chromatography	NULL
plates	NULL
were	NULL
counted	NULL
in	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
Phosphor	NULL
Imager	NULL
and	NULL
are	NULL
presented	NULL
as	NULL
histograms	NULL
indicating	NULL
the	NULL
relative	NULL
CAT	NULL
activity	NULL
above	NULL
that	NULL
of	NULL
vector	NULL
alone	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
average	NULL
of	NULL
two	NULL
independent	NULL
transfections	NULL
.	NULL

Variations	NULL
in	NULL
the	NULL
CAT	NULL
values	NULL
between	NULL
experiments	NULL
were	NULL
usually	NULL
less	NULL
than	NULL
20	NULL
%	NULL
;	NULL
results	NULL
for	NULL
the	NULL
different	NULL
constructs	NULL
are	NULL
representative	NULL
of	NULL
10	NULL
experiments	NULL
in	NULL
$	NULL
194	NULL
,	NULL
MT-2	NULL
,	NULL
and	NULL
EL-4	NULL
cell	NULL
lines	NULL
and	NULL
2	NULL
experiments	NULL
in	NULL
the	NULL
P3X63Ag8	NULL
cell	NULL
line	NULL
.	NULL

Assays	NULL
of	NULL
oligonucleotides	NULL
in	NULL
either	NULL
the	NULL
A56-fos-CAT	NULL
or	NULL
pBLCAT2	NULL
backbones	NULL
gave	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

hancers	NULL
for	NULL
a	NULL
truncated	NULL
c-fos	NULL
promoter	NULL
driving	NULL
the	NULL
bacterial	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
immunoglobulin	NULL
x	NULL
oligonucleotide	NULL
(	NULL
x	NULL
)	NULL
was	NULL
more	NULL
active	NULL
than	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
in	NULL
the	NULL
mouse	NULL
B-cell	NULL
lines	NULL
P3X63¥AG8	NULL
and	NULL
$	NULL
194	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
MT-2	NULL
human	NULL
T-leukemia	NULL
cells	NULL
or	NULL
in	NULL
PMA-stimulated	NULL
EL-4	NULL
mouse	NULL
T-lymphoma	NULL
cells	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
was	NULL
on	NULL
average	NULL
sixfold	NULL
greater	NULL
than	NULL
that	NULL
of	NULL
the	NULL
x	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
c	NULL
oligonucleotide	NULL
worked	NULL
well	NULL
in	NULL
both	NULL
T	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
was	NULL
very	NULL
active	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
worked	NULL
poorly	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
differences	NULL
were	NULL
sur-prising	NULL
,	NULL
because	NULL
each	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
tested	NULL
had	NULL
significant	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
8	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
disparity	NULL
in	NULL
transcriptional	NULL
activity	NULL
VoL	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
P3	NULL
x	NULL
63Ag8	NULL
U	NULL
/s194	NULL
4	NULL
=	NULL
15	NULL
E	NULL
EL4	NULL
,	NULL
unstim	NULL
f	NULL
)	NULL
“	NULL
_	NULL
ela+pma	NULL
]	NULL
I	NULL
10	NULL
CELL	NULL
#	NULL
FLUORESCENCE	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Cell	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
chain	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
IL-2Ra	NULL
chain	NULL
with	NULL
the	NULL
monoclonal	NULL
antibody	NULL
7D4	NULL
to	NULL
stain	NULL
$	NULL
194	NULL
,	NULL
P3X63Ag8	NULL
(	NULL
B	NULL
cells	NULL
[	NULL
dotted	NULL
lines	NULL
]	NULL
)	NULL
,	NULL
and	NULL
resting	NULL
and	NULL
PMA-stimulated	NULL
EL-4	NULL
cells	NULL
or	NULL
the	NULL
monoclonal	NULL
antibody	NULL
anti-Tac	NULL
to	NULL
stain	NULL
the	NULL
MT	NULL
-2	NULL
cell	NULL
line	NULL
(	NULL
T	NULL
cells	NULL
[	NULL
bold	NULL
lines	NULL
]	NULL
)	NULL
.	NULL

The	NULL
vertical	NULL
scale	NULL
represents	NULL
relative	NULL
cell	NULL
number	NULL
,	NULL
while	NULL
the	NULL
horizontal	NULL
scale	NULL
represents	NULL
relative	NULL
log	NULL
scale	NULL
green	NULL
fluorescence	NULL
.	NULL

Each	NULL
sample	NULL
is	NULL
10+	NULL
events	NULL
.	NULL

was	NULL
independent	NULL
of	NULL
the	NULL
orientation	NULL
of	NULL
the	NULL
oligonucleotides	NULL
and	NULL
was	NULL
seen	NULL
when	NULL
CAT	NULL
was	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
instead	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
in	NULL
a	NULL
single	NULL
copy	NULL
worked	NULL
preferentially	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
an	NULL
enhancer	NULL
for	NULL
heterol-ogous	NULL
promoters	NULL
.	NULL

Expression	NULL
of	NULL
p55	NULL
IL2Ra	NULL
«	NULL
protein	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
difference	NULL
in	NULL
oligonucleotide	NULL
activity	NULL
paralleled	NULL
the	NULL
production	NULL
of	NULL
the	NULL
IL-2R	NULL
a	NULL
chain	NULL
(	NULL
p55	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
p55	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Both	NULL
P3	NULL
and	NULL
Competitor	NULL
:	NULL
ng	NULL
:	NULL
1.2.3	NULL
4	NULL
°	NULL
5	NULL
6-7	NULL
5	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
PROBE	NULL
:	NULL
IL-2R	NULL
x	NULL
IL-2R	NULL
x	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

IL-2R	NULL
and	NULL
x	NULL
oligonucleotides	NULL
bind	NULL
the	NULL
NF-kB	NULL
complex	NULL
with	NULL
different	NULL
affinities	NULL
.	NULL

Autoradiogram	NULL
of	NULL
an	NULL
EMSA	NULL
in	NULL
Tris-glycine	NULL
buffer	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
MT-2	NULL
nuclear	NULL
extract	NULL
per	NULL
lane	NULL
and	NULL
0.5	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

Labelled	NULL
oligonucleotide	NULL
probes	NULL
are	NULL
IL-2R	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
9	NULL
to	NULL
12	NULL
)	NULL
and	NULL
x	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
and	NULL
13	NULL
to	NULL
16	NULL
)	NULL
as	NULL
given	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Unlabelled	NULL
oligonucleotide	NULL
competitors	NULL
used	NULL
were	NULL
IL-2R	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
and	NULL
k	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
16	NULL
)	NULL
added	NULL
at	NULL
the	NULL
same	NULL
time	NULL
as	NULL
the	NULL
labelled	NULL
probe	NULL
in	NULL
the	NULL
nanogram	NULL
amounts	NULL
shown	NULL
.	NULL

IL-2Ra	NULL
GENE	NULL
REGULATION	NULL
2539	NULL
H9	NULL
SRF	NULL
H9	NULL
_	NULL
SRF	NULL
H9	NULL
SRF	NULL
i	NULL
Z1	NULL
If	NULL
I	NULL
Competitor	NULL
:	NULL
ILT	NULL
-	NULL
MALT	NULL
ILT	NULL
MALT	NULL
CC	NULL
CC	NULL
&	NULL
om	NULL
al2	NULL
a	NULL
)	NULL
02	NULL
ar	NULL
a	NULL
'	NULL
a	NULL
ng	NULL
:	NULL
I1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
111213	NULL
14416	NULL
16	NULL
ILT	NULL
SRE	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
ILT	NULL
oligonucleotide	NULL
binds	NULL
a	NULL
specific	NULL
complex	NULL
that	NULL
is	NULL
indistinguishable	NULL
from	NULL
SRF	NULL
.	NULL

Autoradiogram	NULL
of	NULL
an	NULL
EMSA	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
per	NULL
lane	NULL
from	NULL
H9	NULL
human	NULL
T-lymphoma	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
,	NULL
10	NULL
,	NULL
12	NULL
,	NULL
and	NULL
15	NULL
)	NULL
or	NULL
SRF	NULL
produced	NULL
from	NULL
an	NULL
in	NULL
vitro	NULL
transcrip-tion-translation	NULL
reaction	NULL
with	NULL
an	NULL
SRF	NULL
coding	NULL
sequence	NULL
plasmid	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
R.	NULL
Treisman	NULL
)	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
and	NULL
16	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
slowest	NULL
migrating	NULL
complex	NULL
is	NULL
specific	NULL
by	NULL
competition	NULL
analysis	NULL
.	NULL

ILT	NULL
or	NULL
SRE	NULL
was	NULL
used	NULL
as	NULL
probes	NULL
as	NULL
indicated	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
same	NULL
apparent	NULL
complex	NULL
is	NULL
detected	NULL
with	NULL
either	NULL
the	NULL
SRE	NULL
or	NULL
the	NULL
ILT	NULL
probe	NULL
which	NULL
comigrates	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
product	NULL
.	NULL

Supershift	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
preincubating	NULL
1	NULL
pl	NULL
of	NULL
either	NULL
preimmune	NULL
serum	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
13	NULL
)	NULL
or	NULL
anti-SRF	NULL
serum	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
14	NULL
)	NULL
.	NULL

$	NULL
194	NULL
B	NULL
cells	NULL
had	NULL
very	NULL
little	NULL
p55	NULL
.	NULL

Unstimulated	NULL
EL-4	NULL
cells	NULL
had	NULL
a	NULL
moderate	NULL
level	NULL
of	NULL
surface	NULL
p55	NULL
that	NULL
was	NULL
elevated	NULL
by	NULL
PMA	NULL
stimulation	NULL
.	NULL

MT	NULL
-2	NULL
cells	NULL
had	NULL
very	NULL
high	NULL
levels	NULL
of	NULL
p55	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
oligonucleotide	NULL
reflects	NULL
appropriate	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
IL-2R	NULL
gene	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

IL-2R	NULL
contains	NULL
a	NULL
weak	NULL
NF-B	NULL
binding	NULL
site	NULL
.	NULL

Because	NULL
the	NULL
exact	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
NF-kB	NULL
binding	NULL
motifs	NULL
differed	NULL
between	NULL
the	NULL
immunoglobulin	NULL
k	NULL
gene	NULL
and	NULL
IL-2R	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
their	NULL
abilities	NULL
to	NULL
bind	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
tested	NULL
.	NULL

In	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
the	NULL
IL-2R	NULL
and	NULL
the	NULL
immunoglobulin	NULL
x	NULL
oligonucleotide	NULL
were	NULL
used	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
with	NULL
either	NULL
oligonucleotide	NULL
with	NULL
an	NULL
MT-2	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
IL-2R	NULL
sequence	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
five	NULL
times	NULL
better	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
formed	NULL
with	NULL
itself	NULL
as	NULL
probe	NULL
than	NULL
with	NULL
the	NULL
immunoglobulin	NULL
k	NULL
sequence	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
8	NULL
)	NULL
.	NULL

The	NULL
immunoglobulin	NULL
k	NULL
sequence	NULL
was	NULL
also	NULL
able	NULL
to	NULL
compete	NULL
five	NULL
times	NULL
better	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
IL-2R	NULL
sequence	NULL
as	NULL
a	NULL
probe	NULL
than	NULL
with	NULL
the	NULL
immunoglobulin	NULL
«	NULL
sequence	NULL
as	NULL
probe	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
either	NULL
probe	NULL
,	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
did	NULL
not	NULL
compete	NULL
as	NULL
effectively	NULL
as	NULL
the	NULL
immunoglobulin	NULL
k	NULL
sequence	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
analyses	NULL
(	NULL
16	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
IL-2R	NULL
sequence	NULL
was	NULL
a	NULL
significantly	NULL
weaker	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
than	NULL
the	NULL
immunoglobulin	NULL
k	NULL
sequence	NULL
,	NULL
which	NULL
seemed	NULL
to	NULL
explain	NULL
why	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
was	NULL
transcriptionally	NULL
less	NULL
active	NULL
in	NULL
B	NULL
cells	NULL
than	NULL
the	NULL
immunoglobulin	NULL
x	NULL
oligonucleotide	NULL
.	NULL

The	NULL
downstream	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
is	NULL
important	NULL
for	NULL
IL-2R	NULL
enhancer	NULL
activity	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
when	NULL
the	NULL
downstream	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
in	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
was	NULL
appended	NULL
to	NULL
the	NULL
immunoglobulin	NULL
xB	NULL
site	NULL
,	NULL
its	NULL
activity	NULL
was	NULL
enhanced	NULL
specifically	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
tested	NULL
the	NULL
IL-2R	NULL
KB	NULL
site	NULL
without	NULL
its	NULL
downstream	NULL
flanking	NULL
sequence	NULL
(	NULL
sIL-2R	NULL
)	NULL
,	NULL
and	NULL
found	NULL
it	NULL
worked	NULL
significantly	NULL
worse	NULL
in	NULL
T	NULL
cells	NULL
than	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
was	NULL
true	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
2540	NULL
KUANG	NULL
ET	NULL
AL	NULL
.	NULL

FIG	NULL
.	NULL

6	NULL
.	NULL

Tissue	NULL
specificity	NULL
of	NULL
the	NULL
SRF-ILT	NULL
nucleoprotein	NULL
complex	NULL
.	NULL

EMSAs	NULL
contained	NULL
the	NULL
radiolabelled	NULL
ILT	NULL
oligonucleotide	NULL
defined	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
protein	NULL
,	NULL
and	NULL
0.5	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
from	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
protein	NULL
concentrations	NULL
in	NULL
all	NULL
nuclear	NULL
extracts	NULL
were	NULL
carefully	NULL
quantitated	NULL
in	NULL
a	NULL
single	NULL
assay	NULL
with	NULL
the	NULL
Bio-Rad	NULL
kit	NULL
just	NULL
prior	NULL
to	NULL
EMSA	NULL
analysis	NULL
.	NULL

Lanes	NULL
2	NULL
to	NULL
4	NULL
,	NULL
B-cell	NULL
lines	NULL
;	NULL
lanes	NULL
5	NULL
to	NULL
12	NULL
,	NULL
T-cell	NULL
lines	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
13	NULL
to	NULL
16	NULL
,	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
specific	NULL
SRF	NULL
complex	NULL
as	NULL
determined	NULL
by	NULL
competition	NULL
assays	NULL
.	NULL

The	NULL
lower	NULL
band	NULL
is	NULL
nonspecific	NULL
by	NULL
competition	NULL
analysis	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
8	NULL
)	NULL
,	NULL
is	NULL
characteristic	NULL
of	NULL
human	NULL
cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
15	NULL
)	NULL
,	NULL
and	NULL
is	NULL
detected	NULL
by	NULL
several	NULL
other	NULL
unrelated	NULL
probes	NULL
(	NULL
23a	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
is	NULL
a	NULL
nonspecific	NULL
binding	NULL
protein	NULL
.	NULL

The	NULL
derivation	NULL
of	NULL
the	NULL
cells	NULL
is	NULL
provided	NULL
in	NULL
Table	NULL
1.	NULL
both	NULL
the	NULL
IL-2R	NULL
and	NULL
sIL-2R	NULL
oligonucleotides	NULL
bound	NULL
NF-	NULL
«	NULL
B	NULL
equivalently	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
downstream	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
B	NULL
site	NULL
or	NULL
mutations	NULL
in	NULL
it	NULL
(	NULL
see	NULL
below	NULL
and	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
did	NULL
not	NULL
activate	NULL
the	NULL
IL-2R	NULL
«	NULL
B	NULL
site	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
was	NULL
therefore	NULL
unlikely	NULL
to	NULL
contain	NULL
a	NULL
site	NULL
for	NULL
repression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
IL-2R	NULL
downstream	NULL
flanking	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
contained	NULL
a	NULL
site	NULL
that	NULL
was	NULL
positively	NULL
regulated	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
might	NULL
account	NULL
for	NULL
why	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
is	NULL
more	NULL
active	NULL
than	NULL
the	NULL
immunoglobulin	NULL
«	NULL
oligonucleotide	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

SRF	NULL
binds	NULL
adjacent	NULL
to	NULL
NF-B	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
apparent	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
sequence	NULL
downstream	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
sequence	NULL
,	NULL
termed	NULL
ILT	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
was	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
nuclear	NULL
factors	NULL
.	NULL

An	NULL
EMSA	NULL
revealed	NULL
several	NULL
nucleoprotein	NULL
complexes	NULL
with	NULL
the	NULL
ILT	NULL
sequence	NULL
with	NULL
extracts	NULL
from	NULL
H9	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
slowest	NULL
migrating	NULL
complex	NULL
bound	NULL
specifically	NULL
,	NULL
since	NULL
wild-type	NULL
(	NULL
ILT	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
but	NULL
not	NULL
mutant	NULL
ILT	NULL
(	NULL
M-ILT	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
sequences	NULL
could	NULL
inhibit	NULL
its	NULL
formation	NULL
.	NULL

The	NULL
faster	NULL
migrating	NULL
complexes	NULL
were	NULL
not	NULL
specifically	NULL
inhibited	NULL
.	NULL

Sequences	NULL
within	NULL
the	NULL
ILT	NULL
oligonucleotide	NULL
resembled	NULL
a	NULL
motif	NULL
called	NULL
CArG	NULL
,	NULL
[	NULL
CC	NULL
(	NULL
A/T	NULL
)	NULL
,	NULL
GG	NULL
]	NULL
,	NULL
which	NULL
binds	NULL
a	NULL
nuclear	NULL
regulatory	NULL
protein	NULL
known	NULL
as	NULL
SRF	NULL
(	NULL
15	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
36	NULL
,	NULL
41	NULL
,	NULL
42	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Others	NULL
have	NULL
previously	NULL
noted	NULL
similarities	NULL
between	NULL
a	NULL
protein	NULL
complex	NULL
with	NULL
the	NULL
IL-2R	NULL
promoter	NULL
and	NULL
SRF	NULL
(	NULL
3	NULL
,	NULL
38	NULL
,	NULL
59	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
compared	NULL
the	NULL
ILT	NULL
complex	NULL
with	NULL
SRF	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
CArG	NULL
box-containing	NULL
oligonucleotide	NULL
derived	NULL
from	NULL
Xenopus	NULL
y-actin	NULL
gene	NULL
sequences	NULL
(	NULL
SRE	NULL
,	NULL
a	NULL
gift	NULL
of	NULL
R.	NULL
Prywes	NULL
)	NULL
.	NULL

The	NULL
SRE	NULL
oligonucleotide	NULL
detected	NULL
a	NULL
comigrating	NULL
complex	NULL
in	NULL
H9	NULL
extracts	NULL
.	NULL

Either	NULL
oligonucleotide	NULL
could	NULL
also	NULL
cross-complete	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
other	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
SRF	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
of	NULL
the	NULL
cDNA	NULL
coding	NULL
sequence	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
either	NULL
the	NULL
ILT	NULL
or	NULL
the	NULL
SRE	NULL
probes	NULL
that	NULL
comigrated	NULL
with	NULL
the	NULL
specific	NULL
ILT	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
10	NULL
,	NULL
15	NULL
,	NULL
and	NULL
16	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Broc	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

Relative	NULL
abundance	NULL
of	NULL
constitutive	NULL
SRF-	NULL
and	NULL
NF-	NULL
«	NULL
B-binding	NULL
activity	NULL
``	NULL
Intensity	NULL
Cell	NULL
type	NULL
and	NULL
Source	NULL
or	NULL
cell	NULL
line	NULL
SRF	NULL
NF-	NULL
«	NULL
B	NULL
reference	NULL
T	NULL
lymphocyte	NULL
Jurkat	NULL
V.	NULL
high	NULL
Low	NULL
ATCC	NULL
Jurkat	NULL
+	NULL
PMA/PHA	NULL
V.	NULL
high	NULL
High	NULL
ATCC	NULL
Jurkat	NULL
+	NULL
rtax	NULL
V.	NULL
high	NULL
Low	NULL
5	NULL
Jurkat	NULL
+	NULL
tax	NULL
V.	NULL
high	NULL
Medium	NULL
5	NULL
Hut	NULL
78	NULL
High	NULL
Medium	NULL
ATCC	NULL
MT2	NULL
Medium	NULL
V.	NULL
high	NULL
8	NULL
CEM	NULL
High	NULL
Low	NULL
ATCC	NULL
CEM	NULL
+	NULL
PMA	NULL
High	NULL
Medium	NULL
ATCC	NULL
CEM	NULL
+	NULL
PMA/CHX	NULL
High	NULL
High	NULL
ATCC	NULL
VB	NULL
V.	NULL
high	NULL
Medium	NULL
28	NULL
H9	NULL
V.	NULL
high	NULL
Medium	NULL
ATCC	NULL
RLM11L	NULL
Medium	NULL
Low	NULL
50	NULL
YAC	NULL
1	NULL
Medium	NULL
Low	NULL
ATCC	NULL
ELA	NULL
High	NULL
Low	NULL
ATCC	NULL
EL4	NULL
+	NULL
PMA	NULL
High	NULL
Medium	NULL
ATCC	NULL
B	NULL
lymphocyte	NULL
$	NULL
194	NULL
Low	NULL
Medium	NULL
ATCC	NULL
P3X63Ag8	NULL
Low	NULL
Medium	NULL
ATCC	NULL
Namalwa	NULL
Low	NULL
Medium	NULL
ATCC	NULL
WEHI	NULL
231	NULL
Low	NULL
High	NULL
50	NULL
BJAB	NULL
Low	NULL
Low	NULL
22	NULL
T70Z/3	NULL
Low	NULL
Low	NULL
50	NULL
EW	NULL
Medium	NULL
High	NULL
50	NULL
BaF3	NULL
Low	NULL
Low	NULL
37	NULL
HAFTL	NULL
Medium	NULL
Low	NULL
50	NULL
38B9	NULL
tk~	NULL
High	NULL
Low	NULL
50	NULL
Nonlymphoid	NULL
HeLa	NULL
Low	NULL
Low	NULL
ATCC	NULL
HeLa	NULL
+	NULL
PMA	NULL
Low	NULL
Medium	NULL
51	NULL
ACHN	NULL
Low	NULL
Low	NULL
ATCC	NULL
K-562	NULL
Low	NULL
Low	NULL
ATCC	NULL
Ad12R1C2	NULL
Low	NULL
Low	NULL
11	NULL
3T3-414G	NULL
Low	NULL
Low	NULL
ATCC	NULL
SK-M-SH	NULL
Low	NULL
Low	NULL
ATCC	NULL
L	NULL
cell	NULL
Low	NULL
Low	NULL
ATCC	NULL
``	NULL
The	NULL
intensities	NULL
of	NULL
the	NULL
nucleoprotein	NULL
complexes	NULL
for	NULL
SRF	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
are	NULL
assigned	NULL
values	NULL
in	NULL
four	NULL
categories	NULL
:	NULL
very	NULL
high	NULL
(	NULL
V.	NULL
high	NULL
)	NULL
,	NULL
high	NULL
,	NULL
medium	NULL
,	NULL
and	NULL
low	NULL
,	NULL
as	NULL
exemplified	NULL
by	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

For	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
p40'*	NULL
molecule	NULL
is	NULL
stably	NULL
expressed	NULL
either	NULL
in	NULL
the	NULL
sense	NULL
(	NULL
tax	NULL
)	NULL
or	NULL
the	NULL
antisense	NULL
(	NULL
rtax	NULL
)	NULL
orientation	NULL
.	NULL

The	NULL
last	NULL
column	NULL
provides	NULL
references	NULL
for	NULL
the	NULL
cell	NULL
lines	NULL
used	NULL
,	NULL
their	NULL
derivation	NULL
,	NULL
and	NULL
in	NULL
certain	NULL
cases	NULL
the	NULL
analysis	NULL
of	NULL
NF-kB	NULL
complex	NULL
.	NULL

ATCC	NULL
,	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

Finally	NULL
,	NULL
antiserum	NULL
against	NULL
SRF	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
R.	NULL
Prywes	NULL
)	NULL
but	NULL
not	NULL
preimmune	NULL
serum	NULL
specifically	NULL
shifted	NULL
both	NULL
the	NULL
ILT	NULL
and	NULL
SRF	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
14	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
band	NULL
above	NULL
SRF	NULL
in	NULL
lanes	NULL
11	NULL
and	NULL
14	NULL
is	NULL
an	NULL
artifact	NULL
resulting	NULL
from	NULL
a	NULL
component	NULL
of	NULL
the	NULL
preimmune	NULL
serum	NULL
interacting	NULL
directly	NULL
with	NULL
the	NULL
DNA	NULL
probe	NULL
.	NULL

Similar	NULL
competition	NULL
and	NULL
supershift	NULL
analyses	NULL
were	NULL
obtained	NULL
by	NULL
comparing	NULL
Jurkat	NULL
and	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
ILT	NULL
complex	NULL
appears	NULL
to	NULL
be	NULL
indistinguishable	NULL
from	NULL
SRF	NULL
.	NULL

SRF	NULL
binding	NULL
is	NULL
present	NULL
at	NULL
higher	NULL
levels	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
the	NULL
abundance	NULL
of	NULL
SRF	NULL
in	NULL
various	NULL
continuously	NULL
cycling	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
found	NULL
that	NULL
T-cell	NULL
lines	NULL
consistently	NULL
exhibited	NULL
high	NULL
levels	NULL
of	NULL
nuclear	NULL
SRF	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
12	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
B	NULL
cells	NULL
or	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
with	NULL
some	NULL
exceptions	NULL
,	NULL
had	NULL
lower	NULL
levels	NULL
of	NULL
nuclear	NULL
SRF	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
13	NULL
to	NULL
16	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
extracts	NULL
derived	NULL
from	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
IL-2R	NULL
«	NULL
GENE	NULL
REGULATION	NULL
2541	NULL
60	NULL
t	NULL
50	NULL
7	NULL
B	NULL
vector	NULL
p	NULL
|	NULL
©	NULL
ior	NULL
E	NULL
B	NULL
Lt	NULL
O	NULL
40	NULL
-	NULL
M1	NULL
<	NULL
O	NULL
mz	NULL
i-	NULL
1	NULL
N	NULL
vs	NULL
3	NULL
»	NULL
|	NULL
-	NULL
8	NULL
%	NULL
L	NULL
4	NULL
a	NULL
>	NULL
»	NULL
F	NULL
20	NULL
7	NULL
<	NULL
4	NULL
wel	NULL
LL	NULL
o	NULL
-	NULL
10	NULL
{	NULL
o	NULL
-	NULL
s	NULL
|	NULL
=S	NULL
$	NULL
194	NULL
EL-4	NULL
unstim	NULL
EL-4	NULL
stim	NULL
Cell	NULL
Line	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

IL-2R	NULL
transcriptional	NULL
activation	NULL
levels	NULL
are	NULL
reduced	NULL
by	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
xB	NULL
or	NULL
SRE	NULL
sequences	NULL
.	NULL

Quantitation	NULL
of	NULL
CAT	NULL
assays	NULL
from	NULL
transfections	NULL
of	NULL
various	NULL
cell	NULL
lines	NULL
with	NULL
reporter	NULL
constructs	NULL
containing	NULL
either	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
or	NULL
derivatives	NULL
with	NULL
mutations	NULL
in	NULL
the	NULL
NF-kB	NULL
site	NULL
(	NULL
M1	NULL
)	NULL
,	NULL
the	NULL
CArG	NULL
box	NULL
(	NULL
M3	NULL
and	NULL
M5	NULL
)	NULL
,	NULL
or	NULL
both	NULL
sites	NULL
(	NULL
M2	NULL
)	NULL
(	NULL
for	NULL
sequences	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Thin-layer	NULL
chromatography	NULL
plates	NULL
were	NULL
counted	NULL
in	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
Phosphor	NULL
Imager	NULL
and	NULL
are	NULL
presented	NULL
as	NULL
histograms	NULL
indicating	NULL
the	NULL
relative	NULL
CAT	NULL
activity	NULL
above	NULL
that	NULL
of	NULL
vector	NULL
alone	NULL
,	NULL
which	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
average	NULL
of	NULL
two	NULL
independent	NULL
transfections	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

Variations	NULL
between	NULL
experiments	NULL
were	NULL
less	NULL
than	NULL
20	NULL
%	NULL
in	NULL
CAT	NULL
values	NULL
;	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

human	NULL
cells	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
15	NULL
)	NULL
but	NULL
not	NULL
mouse	NULL
extracts	NULL
have	NULL
a	NULL
strong	NULL
shifted	NULL
band	NULL
that	NULL
migrates	NULL
faster	NULL
than	NULL
SRF	NULL
,	NULL
but	NULL
this	NULL
band	NULL
is	NULL
not	NULL
specific	NULL
for	NULL
the	NULL
CArG	NULL
box	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
SRF	NULL
contrasted	NULL
with	NULL
the	NULL
distribution	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
which	NULL
was	NULL
constitutively	NULL
present	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
but	NULL
present	NULL
in	NULL
other	NULL
cells	NULL
only	NULL
after	NULL
induction	NULL
by	NULL
stimuli	NULL
such	NULL
as	NULL
by	NULL
p40'**	NULL
,	NULL
PMA	NULL
,	NULL
phytohemagglutinin	NULL
,	NULL
or	NULL
cyclohex-imide	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
SRF	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
these	NULL
stimuli	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

IL-2R	NULL
activity	NULL
depends	NULL
on	NULL
B	NULL
and	NULL
CArG	NULL
sequences	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
whether	NULL
elevated	NULL
levels	NULL
of	NULL
SRF	NULL
in	NULL
T	NULL
cells	NULL
could	NULL
stimulate	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
weak	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
that	NULL
destroy	NULL
binding	NULL
to	NULL
either	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
M1	NULL
)	NULL
,	NULL
the	NULL
CArG	NULL
box	NULL
(	NULL
M3	NULL
and	NULL
MS	NULL
)	NULL
,	NULL
or	NULL
both	NULL
sites	NULL
(	NULL
M2	NULL
)	NULL
(	NULL
for	NULL
sequences	NULL
,	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
either	NULL
site	NULL
drastically	NULL
reduced	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
in	NULL
MT-2	NULL
cells	NULL
or	NULL
in	NULL
stimulated	NULL
EL-4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Altering	NULL
the	NULL
KB	NULL
site	NULL
alone	NULL
or	NULL
both	NULL
the	NULL
kB	NULL
and	NULL
SRE	NULL
sites	NULL
abolished	NULL
activity	NULL
,	NULL
while	NULL
eliminating	NULL
the	NULL
SRE	NULL
site	NULL
reduced	NULL
activity	NULL
to	NULL
the	NULL
level	NULL
seen	NULL
with	NULL
the	NULL
sIL-2R	NULL
oligonucleotide	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

7	NULL
with	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Because	NULL
MT-2	NULL
cells	NULL
have	NULL
unusually	NULL
high	NULL
levels	NULL
of	NULL
NF-KB	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
sIL-2R	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
the	NULL
M3	NULL
and	NULL
MS	NULL
oligonucleotides	NULL
retain	NULL
approximately	NULL
20	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
ILT	NULL
oligonucleotide	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
downstream	NULL
flanking	NULL
sequencing	NULL
alone	NULL
,	NULL
had	NULL
only	NULL
variable	NULL
or	NULL
low	NULL
enhancer	NULL
activity	NULL
that	NULL
could	NULL
not	NULL
account	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
ILT	NULL
)	NULL
.	NULL

The	NULL
combined	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
«	NULL
B	NULL
and	NULL
SRE	NULL
sites	NULL
in	NULL
the	NULL
complete	NULL
IL-2R	NULL
oligonucleotide	NULL
appeared	NULL
to	NULL
be	NULL
greater	NULL
than	NULL
the	NULL
contribution	NULL
of	NULL
either	NULL
site	NULL
alone	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
SRF	NULL
bind	NULL
simultaneously	NULL
to	NULL
IL-2R	NULL
.	NULL

We	NULL
next	NULL
tested	NULL
by	NULL
EMSA	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
SRF	NULL
could	NULL
bind	NULL
simultaneously	NULL
with	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

This	NULL
revealed	NULL
the	NULL
formation	NULL
of	NULL
four	NULL
complexes	NULL
with	NULL
either	NULL
MT-2	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
14	NULL
)	NULL
or	NULL
EL-4	NULL
plus	NULL
PMA	NULL
(	NULL
lanes	NULL
15	NULL
to	NULL
24	NULL
)	NULL
nuclear	NULL
extracts	NULL
.	NULL

For	NULL
either	NULL
extract	NULL
,	NULL
competition	NULL
with	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
itself	NULL
diminished	NULL
binding	NULL
of	NULL
the	NULL
three	NULL
complexes	NULL
of	NULL
slowest	NULL
mobility	NULL
(	NULL
labeled	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
)	NULL
,	NULL
indicating	NULL
these	NULL
were	NULL
specific	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
15	NULL
to	NULL
18	NULL
,	NULL
and	NULL
for	NULL
EL-4	NULL
,	NULL
seen	NULL
more	NULL
clearly	NULL
in	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
)	NULL
.	NULL

The	NULL
most	NULL
rapidly	NULL
migrating	NULL
complex	NULL
is	NULL
the	NULL
nonspecific	NULL
band	NULL
previously	NULL
seen	NULL
in	NULL
human	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Complex	NULL
2	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutant	NULL
CArG	NULL
box	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
M3	NULL
,	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
or	NULL
an	NULL
irrelevant	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
X	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
13	NULL
)	NULL
,	NULL
suggesting	NULL
it	NULL
was	NULL
the	NULL
SRF	NULL
complex	NULL
.	NULL

Complex	NULL
3	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
a	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
M1	NULL
,	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
or	NULL
an	NULL
irrelevant	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
X	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
13	NULL
)	NULL
,	NULL
suggesting	NULL
it	NULL
was	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
SRF	NULL
was	NULL
supported	NULL
by	NULL
comparison	NULL
to	NULL
complexes	NULL
obtained	NULL
with	NULL
known	NULL
«	NULL
B	NULL
and	NULL
SRE	NULL
probes	NULL
from	NULL
other	NULL
genes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Interest-ingly	NULL
,	NULL
complex	NULL
1	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
either	NULL
mutant	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
the	NULL
irrelevant	NULL
oligonucleotide	NULL
(	NULL
X	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
represented	NULL
the	NULL
binding	NULL
of	NULL
both	NULL
SRF	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
abundance	NULL
of	NULL
complex	NULL
1	NULL
was	NULL
less	NULL
than	NULL
the	NULL
individual	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
SRF	NULL
complexes	NULL
,	NULL
suggesting	NULL
there	NULL
was	NULL
not	NULL
significant	NULL
cooperativity	NULL
in	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

Antibody	NULL
supershift	NULL
studies	NULL
confirmed	NULL
that	NULL
complexes	NULL
1	NULL
and	NULL
2	NULL
contained	NULL
SRF	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
complexes	NULL
1	NULL
and	NULL
3	NULL
,	NULL
but	NULL
not	NULL
SRF	NULL
,	NULL
could	NULL
be	NULL
inhibited	NULL
with	NULL
IxB	NULL
,	NULL
suggesting	NULL
they	NULL
both	NULL
contain	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
a	NULL
related	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
,	NULL
8	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
immunoglobulin	NULL
«	NULL
B	NULL
site	NULL
or	NULL
the	NULL
Xeropus	NULL
y-actin	NULL
SRE	NULL
site	NULL
could	NULL
inhibit	NULL
complex	NULL
1	NULL
as	NULL
well	NULL
as	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
SRF	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
the	NULL
close	NULL
proximity	NULL
of	NULL
their	NULL
binding	NULL
sites	NULL
,	NULL
a	NULL
ternary	NULL
complex	NULL
of	NULL
an	NULL
2542	NULL
KUANG	NULL
ET	NULL
AL	NULL
.	NULL

PMA	NULL
Extract	NULL
bd	NULL
8	NULL
HHH	NULL
|	NULL
,	NULL
bi	NULL
fea	NULL
|	NULL
T|	NULL
|T	NULL
11	NULL
t	NULL
t	NULL
ts	NULL
45	NULL
as	NULL
tb	NULL
us	NULL
--	NULL
th	NULL
66	NULL
to	NULL
uo	NULL
8	NULL
9	NULL
1	NULL
19	NULL
>	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
EL	NULL
-	NULL
4	NULL
C	NULL
``	NULL
IL-2R	NULL
probe	NULL
|	NULL
+	NULL
WP	NULL
ﬂ	NULL
‘	NULL
ioh	NULL
f	NULL
a	NULL
IL	NULL
T	NULL
probe	NULL
[	NULL
>	NULL
:	NULL
BBE	NULL
|	NULL
®	NULL
ig-xB	NULL
DNA	NULL
[	NULL
4	NULL
]	NULL
s	NULL
]	NULL
-|	NULL
-|-mal	NULL
|	NULL
|	NULL
b	NULL
sreona	NULL
[	NULL
-|-	NULL
|-	NULL
|-	NULL
|-|4	NULL
]	NULL
8	NULL
]	NULL
-	NULL
]	NULL
``	NULL
!	NULL

ﬂ	NULL
“	NULL
.	NULL

l-xB	NULL
‘	NULL
2	NULL
25|	NULL
-	NULL
|-	NULL
—	NULL
?	NULL

W2	NULL
>	NULL
®	NULL
Lane	NULL
L1	NULL
2	NULL
3L415	NULL
6	NULL
FEB	NULL
9	NULL
|	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

The	NULL
IL-2R	NULL
oligonucleotide	NULL
binds	NULL
NF-kB	NULL
,	NULL
SRF	NULL
,	NULL
and	NULL
both	NULL
proteins	NULL
together	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
with	NULL
radiolabelled	NULL
IL-2R	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

A	NULL
total	NULL
of	NULL
5	NULL
ug	NULL
of	NULL
MT-2	NULL
nuclear	NULL
extract	NULL
per	NULL
lane	NULL
was	NULL
added	NULL
in	NULL
lanes	NULL
1	NULL
to	NULL
14	NULL
,	NULL
5	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
EL-4	NULL
cells	NULL
stimulated	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
3	NULL
h	NULL
was	NULL
added	NULL
to	NULL
each	NULL
of	NULL
lanes	NULL
15	NULL
to	NULL
26	NULL
.	NULL

Unlabelled	NULL
oligonucleotide	NULL
competitors	NULL
are	NULL
IL-2R	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
4	NULL
and	NULL
15	NULL
to	NULL
18	NULL
)	NULL
,	NULL
IL-2Rm1	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
and	NULL
19	NULL
to	NULL
21	NULL
)	NULL
,	NULL
IL-2Rm3	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
and	NULL
22	NULL
to	NULL
24	NULL
)	NULL
,	NULL
and	NULL
X	NULL
,	NULL
which	NULL
is	NULL
a	NULL
26-bp	NULL
oligonucleotide	NULL
of	NULL
random	NULL
sequence	NULL
{	NULL
lanes	NULL
11	NULL
to	NULL
14	NULL
)	NULL
.	NULL

Arrow	NULL
1	NULL
points	NULL
to	NULL
the	NULL
specific	NULL
complex	NULL
containing	NULL
both	NULL
the	NULL
SRF	NULL
and	NULL
NF-xB	NULL
complexed	NULL
with	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
.	NULL

Arrow	NULL
2	NULL
indicates	NULL
the	NULL
SRF	NULL
complex	NULL
alone	NULL
,	NULL
and	NULL
arrow	NULL
3	NULL
indicates	NULL
the	NULL
NF-kB	NULL
complex	NULL
alone	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
showing	NULL
competition	NULL
as	NULL
in	NULL
lanes	NULL
15	NULL
to	NULL
18	NULL
of	NULL
panel	NULL
A	NULL
.	NULL

Lanes	NULL
5	NULL
and	NULL
6	NULL
are	NULL
samples	NULL
with	NULL
no	NULL
competitor	NULL
,	NULL
and	NULL
for	NULL
lane	NULL
6	NULL
,	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
preincubated	NULL
with	NULL
anti-SRF	NULL
antiserum	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
for	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
low-ionic-strength	NULL
Tris-acetate	NULL
buffer	NULL
(	NULL
20	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
with	NULL
either	NULL
the	NULL
IL-2R	NULL
probe	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
7	NULL
)	NULL
or	NULL
the	NULL
ILT	NULL
probe	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
in	NULL
which	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
untreated	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
the	NULL
indicated	NULL
volumes	NULL
(	NULL
in	NULL
microliters	NULL
)	NULL
of	NULL
I-kB	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Competitions	NULL
used	NULL
either	NULL
the	NULL
immunoglobulin	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
or	NULL
the	NULL
Xenopus	NULL
actin	NULL
SRE	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
in	NULL
the	NULL
nanogram	NULL
amounts	NULL
shown	NULL
.	NULL

NF-	NULL
«	NULL
B-like	NULL
protein	NULL
complex	NULL
,	NULL
SRF	NULL
,	NULL
and	NULL
DNA	NULL
could	NULL
be	NULL
demonstrated	NULL
in	NULL
vitro	NULL
.	NULL

Overexpression	NULL
of	NULL
SRF	NULL
drives	NULL
IL-2R	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
experiments	NULL
suggest	NULL
that	NULL
SRF-	NULL
and	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
collaborate	NULL
to	NULL
positively	NULL
activate	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
lower	NULL
constitutive	NULL
levels	NULL
of	NULL
SRF	NULL
binding	NULL
in	NULL
B	NULL
cells	NULL
might	NULL
therefore	NULL
be	NULL
rate	NULL
limiting	NULL
for	NULL
IL-2R	NULL
enhancer	NULL
expression	NULL
.	NULL

This	NULL
would	NULL
differ	NULL
from	NULL
growth	NULL
factor	NULL
regulation	NULL
in	NULL
which	NULL
the	NULL
level	NULL
of	NULL
SRF	NULL
binding	NULL
activity	NULL
appears	NULL
not	NULL
to	NULL
be	NULL
rate	NULL
limiting	NULL
during	NULL
serum	NULL
activation	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
13	NULL
,	NULL
18	NULL
,	NULL
46	NULL
)	NULL
.	NULL

To	NULL
test	NULL
this	NULL
idea	NULL
,	NULL
we	NULL
overexpressed	NULL
SRF	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
constructing	NULL
a	NULL
chimeric	NULL
gene	NULL
in	NULL
which	NULL
the	NULL
SRF	NULL
coding	NULL
sequence	NULL
was	NULL
expressed	NULL
by	NULL
a	NULL
FBJ-MSV	NULL
retroviral	NULL
promoter	NULL
(	NULL
48	NULL
)	NULL
.	NULL

This	NULL
chimeric	NULL
gene	NULL
(	NULL
BKSRF	NULL
)	NULL
was	NULL
transfected	NULL
in	NULL
increasing	NULL
amounts	NULL
together	NULL
with	NULL
the	NULL
IL-2R	NULL
enhancer/reporter	NULL
plasmid	NULL
into	NULL
$	NULL
194	NULL
B	NULL
cells	NULL
which	NULL
have	NULL
little	NULL
SRF	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
retroviral	NULL
promoter	NULL
plasmid	NULL
without	NULL
SRF	NULL
coding	NULL
sequences	NULL
(	NULL
BK	NULL
)	NULL
was	NULL
added	NULL
to	NULL
maintain	NULL
a	NULL
constant	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
the	NULL
transfection	NULL
.	NULL

As	NULL
shown	NULL
previously	NULL
,	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
alone	NULL
had	NULL
little	NULL
activity	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IL-2R	NULL
enhancer	NULL
activity	NULL
was	NULL
increased	NULL
3-	NULL
and	NULL
8.5-fold	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
5	NULL
and	NULL
10	NULL
ug	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
BKSRF	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
SRF	NULL
had	NULL
either	NULL
variable	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
immunoglobulin	NULL
k	NULL
oligonucleotide	NULL
(	NULL
x	NULL
)	NULL
or	NULL
the	NULL
CAT	NULL
backbone	NULL
(	NULL
A56	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
SRF	NULL
gave	NULL
quantitatively	NULL
no	NULL
induction	NULL
of	NULL
IL-2R	NULL
expression	NULL
in	NULL
EL-4	NULL
cells	NULL
or	NULL
the	NULL
M3	NULL
mutant	NULL
oligonucleotide	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
.	NULL

In	NULL
further	NULL
experiments	NULL
,	NULL
10	NULL
pug	NULL
of	NULL
a	NULL
plasmid	NULL
overexpressing	NULL
SRF	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
by	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
increased	NULL
IL-ZR	NULL
expression	NULL
threefold	NULL
in	NULL
$	NULL
194	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
antisense	NULL
orientation	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

In	NULL
EL-4	NULL
cells	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
orientation	NULL
of	NULL
SRF	NULL
gave	NULL
almost	NULL
the	NULL
same	NULL
CAT	NULL
activity	NULL
as	NULL
the	NULL
backbone	NULL
alone	NULL
(	NULL
23a	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
levels	NULL
of	NULL
SRF	NULL
can	NULL
be	NULL
rate	NULL
limiting	NULL
for	NULL
transcriptional	NULL
activation	NULL
and	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
elevated	NULL
SRF	NULL
in	NULL
T	NULL
cells	NULL
contributes	NULL
to	NULL
the	NULL
increased	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
element	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
investigation	NULL
was	NULL
prompted	NULL
by	NULL
the	NULL
intriguing	NULL
question	NULL
of	NULL
how	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
,	NULL
induced	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
signals	NULL
,	NULL
activate	NULL
only	NULL
certain	NULL
genes	NULL
in	NULL
specific	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Our	NULL
previous	NULL
study	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
in	NULL
the	NULL
IL-ZRa	NULL
«	NULL
promoter	NULL
suggested	NULL
that	NULL
the	NULL
site	NULL
had	NULL
selective	NULL
activity	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
further	NULL
dissected	NULL
this	NULL
element	NULL
and	NULL
found	NULL
that	NULL
its	NULL
preferential	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
NF-kB	NULL
and	NULL
SRF	NULL
binding	NULL
sites	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
found	NULL
SRF	NULL
binding	NULL
activity	NULL
to	NULL
be	NULL
consistently	NULL
higher	NULL
in	NULL
T-lymphoid	NULL
tumor	NULL
lines	NULL
than	NULL
in	NULL
other	NULL
continuously	NULL
cycling	NULL
tumor	NULL
cells	NULL
.	NULL

The	NULL
combined	NULL
action	NULL
of	NULL
NF-kB	NULL
and	NULL
SRF	NULL
appeared	NULL
to	NULL
be	NULL
due	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
complex	NULL
including	NULL
both	NULL
factors	NULL
and	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
.	NULL

Finally	NULL
,	NULL
overexpression	NULL
of	NULL
SRF	NULL
in	NULL
a	NULL
B-cell	NULL
line	NULL
activated	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
oligonucleotide	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
level	NULL
of	NULL
SRF	NULL
in	NULL
the	NULL
cell	NULL
,	NULL
and	NULL
not	NULL
other	NULL
posttranslational	NULL
effects	NULL
,	NULL
is	NULL
rate	NULL
limiting	NULL
for	NULL
IL-2R	NULL
enhancer	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

One	NULL
plausible	NULL
explanation	NULL
for	NULL
the	NULL
functional	NULL
differences	NULL
between	NULL
the	NULL
immunoglobulin	NULL
x	NULL
and	NULL
IL-2R	NULL
elements	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
is	NULL
that	NULL
different	NULL
members	NULL
of	NULL
the	NULL
Rel	NULL
gene	NULL
family	NULL
or	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
1	NULL
)	NULL
specifically	NULL
regulate	NULL
these	NULL
sites	NULL
.	NULL

Several	NULL
aspects	NULL
of	NULL
our	NULL
data	NULL
are	NULL
incompatible	NULL
with	NULL
this	NULL
hypothesis	NULL
:	NULL
(	NULL
i	NULL
)	NULL
the	NULL
sIL-2R	NULL
oligonucleotide	NULL
had	NULL
much	NULL
less	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
BKSRF	NULL
A56	NULL
IL-2R	NULL
``	NULL
o	NULL
ppr	NULL
sero	NULL
ug	NULL
BK	NULL
``	NULL
15	NULL
5	NULL
0	NULL
10	NULL
5	NULL
0	NULL
15	NULL
5	NULL
0	NULL
ug	NULL
BKSRF	NULL
0	NULL
10	NULL
15	NULL
0	NULL
5	NULL
10	NULL
0	NULL
10	NULL
15	NULL
Relative	NULL
acetyl	NULL
.	NULL

1	NULL
1	NULL
1	NULL
1	NULL
3.1	NULL
8.5	NULL
4.2	NULL
2.7	NULL
3.8	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

SRF	NULL
overexpression	NULL
activates	NULL
transcription	NULL
of	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
in	NULL
$	NULL
194	NULL
B	NULL
cells	NULL
.	NULL

Above	NULL
is	NULL
shown	NULL
the	NULL
chimeric	NULL
gene	NULL
construction	NULL
used	NULL
to	NULL
overexpress	NULL
SRF	NULL
coding	NULL
sequence	NULL
by	NULL
a	NULL
strong	NULL
viral	NULL
promoter/enhancer	NULL
from	NULL
the	NULL
FBJ-MSV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
I.	NULL
Verma	NULL
)	NULL
.	NULL

In	NULL
the	NULL
middle	NULL
is	NULL
shown	NULL
the	NULL
thin-layer	NULL
chromatographic	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
from	NULL
the	NULL
transfected	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
CAT	NULL
reporter	NULL
construct	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
SRF	NULL
expression	NULL
vector	NULL
BKSRF	NULL
(	NULL
in	NULL
micro-grams	NULL
as	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
expression	NULL
vector	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
addition	NULL
of	NULL
BK~	NULL
(	NULL
vector	NULL
without	NULL
the	NULL
SRF	NULL
cDNA	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
constructs	NULL
were	NULL
either	NULL
the	NULL
A56	NULL
backbone	NULL
(	NULL
A56	NULL
)	NULL
,	NULL
the	NULL
IL-2R-fos-CAT	NULL
construct	NULL
(	NULL
IL-2R	NULL
)	NULL
,	NULL
or	NULL
the	NULL
<	NULL
-fos-CAT	NULL
construct	NULL
(	NULL
kappa	NULL
)	NULL
.	NULL

Below	NULL
are	NULL
given	NULL
the	NULL
amounts	NULL
of	NULL
DNA	NULL
used	NULL
and	NULL
quantitation	NULL
of	NULL
the	NULL
relative	NULL
acetylation	NULL
of	NULL
chloramphenicol	NULL
relative	NULL
to	NULL
the	NULL
A56	NULL
backbone	NULL
value	NULL
.	NULL

Absolute	NULL
percent	NULL
conversion	NULL
for	NULL
the	NULL
samples	NULL
(	NULL
from	NULL
left	NULL
to	NULL
right	NULL
)	NULL
were	NULL
A56	NULL
,	NULL
0.18	NULL
,	NULL
0.11	NULL
,	NULL
and	NULL
0.13	NULL
;	NULL
IL-2R	NULL
(	NULL
run	NULL
in	NULL
a	NULL
separate	NULL
assay	NULL
in	NULL
which	NULL
A56	NULL
and	NULL
J14	NULL
gave	NULL
0.7	NULL
to	NULL
12	NULL
%	NULL
acetylation	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
0.6	NULL
,	NULL
2.9	NULL
,	NULL
and	NULL
5.2	NULL
;	NULL
and	NULL
kappa	NULL
,	NULL
0.76	NULL
,	NULL
0.49	NULL
,	NULL
and	NULL
0.69	NULL
.	NULL

Variations	NULL
in	NULL
the	NULL
CAT	NULL
values	NULL
between	NULL
experiments	NULL
were	NULL
less	NULL
than	NULL
20	NULL
%	NULL
;	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

activity	NULL
than	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
in	NULL
T	NULL
cells	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
they	NULL
competed	NULL
equivalently	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
mutations	NULL
in	NULL
the	NULL
CArG	NULL
box	NULL
dramatically	NULL
decreased	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
oligonucleotide	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
SRF	NULL
overexpression	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2R	NULL
but	NULL
not	NULL
the	NULL
x	NULL
oligonucleotide	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
pieces	NULL
of	NULL
evidence	NULL
points	NULL
toward	NULL
a	NULL
functional	NULL
importance	NULL
of	NULL
the	NULL
downstream	NULL
flanking	NULL
sequence	NULL
of	NULL
the	NULL
IL-Z2R	NULL
oligonucleotide	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
SRF	NULL
binding	NULL
site	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
a	NULL
repressor	NULL
acts	NULL
at	NULL
the	NULL
SRE	NULL
sequence	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
we	NULL
have	NULL
failed	NULL
to	NULL
find	NULL
evidence	NULL
that	NULL
this	NULL
sequence	NULL
can	NULL
repress	NULL
positive	NULL
elements	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
when	NULL
removed	NULL
or	NULL
mutated	NULL
does	NULL
not	NULL
increase	NULL
sIL-2R	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
7	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
favor	NULL
the	NULL
hypothesis	NULL
that	NULL
both	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
Rel	NULL
protein	NULL
complex	NULL
,	NULL
probably	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
that	NULL
will	NULL
activate	NULL
the	NULL
IL-ZR	NULL
site	NULL
but	NULL
only	NULL
in	NULL
cooperation	NULL
with	NULL
SRF	NULL
.	NULL

Though	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
cooperativity	NULL
in	NULL
binding	NULL
in	NULL
vitro	NULL
,	NULL
one	NULL
model	NULL
is	NULL
that	NULL
in	NULL
vivo	NULL
,	NULL
SRF	NULL
is	NULL
capable	NULL
of	NULL
recruiting	NULL
NF-kB	NULL
to	NULL
its	NULL
adjacent	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
this	NULL
mechanism	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
IL-2Re	NULL
GENE	NULL
REGULATION	NULL
2543	NULL
gene	NULL
is	NULL
supported	NULL
by	NULL
previous	NULL
studies	NULL
in	NULL
which	NULL
mutations	NULL
in	NULL
the	NULL
sequences	NULL
that	NULL
bind	NULL
SRF	NULL
severely	NULL
impair	NULL
IL-2Ra	NULL
promoter	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
59	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
previous	NULL
studies	NULL
do	NULL
not	NULL
address	NULL
the	NULL
contribution	NULL
of	NULL
SRF	NULL
to	NULL
T-cell	NULL
specificity	NULL
in	NULL
the	NULL
IL-2R	NULL
gene	NULL
,	NULL
because	NULL
the	NULL
promoter	NULL
mutants	NULL
and	NULL
levels	NULL
of	NULL
binding	NULL
activity	NULL
were	NULL
not	NULL
examined	NULL
in	NULL
non-T	NULL
cells	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
SRF	NULL
contributes	NULL
importantly	NULL
to	NULL
T-cell	NULL
specificity	NULL
of	NULL
the	NULL
IL-2R	NULL
enhancer	NULL
.	NULL

Recent	NULL
evidence	NULL
suggests	NULL
that	NULL
c-re/	NULL
also	NULL
activates	NULL
the	NULL
IL-2R	NULL
B	NULL
site	NULL
and	NULL
thus	NULL
contributes	NULL
to	NULL
its	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
57	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
if	NULL
SRF	NULL
can	NULL
interact	NULL
directly	NULL
with	NULL
any	NULL
member	NULL
of	NULL
the	NULL
Rel	NULL
protein	NULL
family	NULL
.	NULL

Our	NULL
studies	NULL
revealed	NULL
a	NULL
surprising	NULL
facet	NULL
of	NULL
the	NULL
biology	NULL
of	NULL
SRF	NULL
.	NULL

Previously	NULL
,	NULL
SRF	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
gene	NULL
induction	NULL
by	NULL
serum	NULL
and	NULL
growth	NULL
factors	NULL
and	NULL
muscle-specific	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
now	NULL
propose	NULL
that	NULL
SRF	NULL
can	NULL
be	NULL
used	NULL
by	NULL
T	NULL
cells	NULL
for	NULL
tissue-specific	NULL
gene	NULL
activation	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
control	NULL
may	NULL
differ	NULL
with	NULL
regulation	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
by	NULL
serum	NULL
or	NULL
growth	NULL
factors	NULL
(	NULL
18	NULL
,	NULL
46	NULL
,	NULL
52	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
SRF-p62	NULL
interaction	NULL
,	NULL
which	NULL
may	NULL
take	NULL
part	NULL
in	NULL
c-fos	NULL
regula-tion	NULL
,	NULL
is	NULL
mediated	NULL
through	NULL
DNA	NULL
sequences	NULL
that	NULL
flank	NULL
the	NULL
CArG	NULL
box	NULL
in	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

These	NULL
sequences	NULL
are	NULL
absent	NULL
from	NULL
the	NULL
flanks	NULL
of	NULL
the	NULL
CArG	NULL
box	NULL
in	NULL
the	NULL
IL-Z2Ra	NULL
«	NULL
promoter	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
coactivator	NULL
molecule	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
HeLa	NULL
cells	NULL
that	NULL
stimulates	NULL
transcription	NULL
by	NULL
SRF	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Such	NULL
coacti-vators	NULL
may	NULL
further	NULL
regulate	NULL
the	NULL
transcriptional	NULL
response	NULL
to	NULL
SRF	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
there	NULL
are	NULL
multiple	NULL
pathways	NULL
of	NULL
gene	NULL
regulation	NULL
through	NULL
SRF	NULL
.	NULL

Regulation	NULL
of	NULL
IL-2Ra	NULL
«	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
depends	NULL
on	NULL
antigen	NULL
stimulation	NULL
.	NULL

However	NULL
,	NULL
IL-2R	NULL
«	NULL
expression	NULL
during	NULL
thymic	NULL
development	NULL
occurs	NULL
in	NULL
a	NULL
transient	NULL
stage	NULL
before	NULL
T-cell	NULL
receptor	NULL
genes	NULL
are	NULL
rearranged	NULL
and	NULL
expressed	NULL
.	NULL

This	NULL
would	NULL
seem	NULL
to	NULL
preclude	NULL
any	NULL
involvement	NULL
of	NULL
antigen-receptor	NULL
signalling	NULL
in	NULL
inducing	NULL
IL-2Ra	NULL
«	NULL
early	NULL
in	NULL
T-cell	NULL
development	NULL
.	NULL

Recently	NULL
we	NULL
have	NULL
found	NULL
that	NULL
SRF	NULL
binding	NULL
activity	NULL
is	NULL
abundant	NULL
early	NULL
in	NULL
thymocyte	NULL
development	NULL
at	NULL
the	NULL
double-negative	NULL
stage	NULL
(	NULL
65	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
SRF	NULL
participate	NULL
in	NULL
this	NULL
earlier	NULL
,	NULL
presumably	NULL
antigen-independent	NULL
,	NULL
expression	NULL
of	NULL
IL-Z2Ra	NULL
«	NULL
during	NULL
T-lymphocyte	NULL
ontogeny	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
A.A.K	NULL
.	NULL

and	NULL
K.D.N	NULL
.	NULL

are	NULL
equal	NULL
first	NULL
authors	NULL
.	NULL

We	NULL
thank	NULL
Hieu	NULL
Dang	NULL
and	NULL
Di	NULL
Jiang	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
Albert	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
,	NULL
Ron	NULL
Prywes	NULL
,	NULL
Richard	NULL
Treisman	NULL
,	NULL
and	NULL
Inder	NULL
Verma	NULL
for	NULL
reagents	NULL
;	NULL
and	NULL
Warren	NULL
Leonard	NULL
and	NULL
Sharon	NULL
Cross	NULL
for	NULL
helpful	NULL
discussions	NULL
in	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
this	NULL
work	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
David	NULL
Baltimore	NULL
,	NULL
in	NULL
whose	NULL
laboratory	NULL
this	NULL
project	NULL
was	NULL
conceived	NULL
.	NULL

M.J.L	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
an	NULL
Investigator	NULL
Award	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Institute	NULL
.	NULL

S.-M.K	NULL
.	NULL

is	NULL
an	NULL
NIH-Howard	NULL
Hughes	NULL
Medical	NULL
Institutes	NULL
Research	NULL
Scholar	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Adams	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
E.	NULL
W.	NULL
Hanley	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
R	NULL
kappa	NULL
B	NULL
,	NULL
a	NULL
novel	NULL
DNA-binding	NULL
protein	NULL
that	NULL
recognizes	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
kappa	NULL
B	NULL
site	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

3:1063-1071	NULL
.	NULL

2	NULL
.	NULL

Baeuerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

3	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoffman	NULL
,	NULL
H.	NULL
P.	NULL
Bogerd	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
gene	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
DNA-protein	NULL
interactions	NULL
flanking	NULL
the	NULL
xB	NULL
enhancer	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

1:83-92	NULL
.	NULL

4	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
§3:827-836	NULL
.	NULL

2544	NULL
5	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

KUANG	NULL
ET	NULL
AL	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
L.	NULL
Rimsky	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
J.	NULL
Hoffman	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
human	NULL
immunodefi-ciency	NULL
virus	NULL
type	NULL
1	NULL
enhance	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
tax	NULL
gene	NULL
product	NULL
involves	NULL
the	NULL
action	NULL
of	NULL
inducible	NULL
cellular	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1578-1586.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.-P.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50/p105/NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
kB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
B	NULL
DNA-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80.	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
M.	NULL
J.	NULL
Lenardo	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1989	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-	NULL
<	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
immunoglobulin	NULL
xk	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244:466-469.	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
D.	NULL
L.	NULL
Simmons	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Bose	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Science	NULL
253:1268-1271	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebowitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

Friend	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
R.	NULL
Bernards	NULL
,	NULL
S.	NULL
Rogelj	NULL
,	NULL
R.	NULL
A.	NULL
Weinberg	NULL
,	NULL
R.	NULL
A.	NULL
Rapaport	NULL
,	NULL
D.	NULL
M.	NULL
Albert	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Dryja	NULL
,	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
human	NULL
DNA	NULL
segment	NULL
with	NULL
properties	NULL
of	NULL
the	NULL
gene	NULL
that	NULL
predisposes	NULL
to	NULL
retino-blastoma	NULL
and	NULL
osteosarcoma	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323:643-646	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Rivere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
:	NULL
homology	NULL
to	NULL
re	NULL
?	NULL

and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029	NULL
.	NULL

Gilman	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
R.	NULL
N.	NULL
Wilson	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Weinberg	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
regulate	NULL
c-fos	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:4305-4316	NULL
.	NULL

Graham	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Gilman	NULL
.	NULL

1991	NULL
.	NULL

Distinct	NULL
protein	NULL
targets	NULL
for	NULL
signals	NULL
acting	NULL
at	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Science	NULL
25:189-192	NULL
.	NULL

Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Z.	NULL
Siegfried	NULL
,	NULL
and	NULL
E.	NULL
B.	NULL
Ziff	NULL
.	NULL

1987	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
dyad	NULL
symmetry	NULL
element	NULL
inhibits	NULL
serum	NULL
inducibility	NULL
of	NULL
transcription	NULL
in	NULL
vivo	NULL
and	NULL
the	NULL
nuclear	NULL
regulatory	NULL
factor	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:1217-1225	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.-S.	NULL
Chin	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-kB	NULL
and	NULL
Rel~	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

143:1-62	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
D.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Herrera	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
P.	NULL
E.	NULL
Shaw	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1989	NULL
.	NULL

Occupation	NULL
of	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
in	NULL
vivo	NULL
by	NULL
a	NULL
multi-protein	NULL
complex	NULL
is	NULL
unaltered	NULL
by	NULL
growth	NULL
factor	NULL
induction	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
340:68-70	NULL
.	NULL

Jamieson	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1991	NULL
.	NULL

Physiologic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
induces	NULL
NF-kappa	NULL
B.	NULL
J.	NULL
Immunol	NULL
.	NULL

147:416-420	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
A.-C.	NULL
Tran	NULL
,	NULL
M.	NULL
Grilli	NULL
,	NULL
and	NULL
M.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformal	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256:1452-1456	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vanderkerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF-1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
re/	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Klein	NULL
,	NULL
G.	NULL
,	NULL
T.	NULL
Lindahl	NULL
,	NULL
M.	NULL
Jondal	NULL
,	NULL
W.	NULL
Leibold	NULL
,	NULL
J.	NULL
Menezes	NULL
,	NULL
K.	NULL
Nilsson	NULL
,	NULL
and	NULL
C.	NULL
Sundstrom	NULL
.	NULL

1974	NULL
.	NULL

Continuous	NULL
lymphoid	NULL
cell	NULL
lines	NULL
with	NULL
characteristics	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
bone-marrow-derived	NULL
)	NULL
,	NULL
lacking	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
genome	NULL
and	NULL
derived	NULL
from	NULL
three	NULL
human	NULL
lymphomas	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
71:3283-3286	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

1991	NULL
.	NULL

Interleukin-2	NULL
programs	NULL
mouse	NULL
aB	NULL
T-lym-phocytes	NULL
for	NULL
apoptosis	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
353:858-861	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

23a.Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
C.-M	NULL
.	NULL

Fan	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
D.	NULL
Baitimore	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
NF-kB	NULL
in	NULL
B-interferon	NULL
gene	NULL
regulation	NULL
reveals	NULL
its	NULL
role	NULL
as	NULL
widely	NULL
inducible	NULL
mediator	NULL
of	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Cell	NULL
57:287-294	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
W.	NULL
Pierce	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

Protein-binding	NULL
sites	NULL
in	NULL
Ig	NULL
gene	NULL
enhancers	NULL
determine	NULL
transcriptional	NULL
activity	NULL
and	NULL
inducibility	NULL
.	NULL

Science	NULL
236:1573-1577	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Lifson	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
G.	NULL
R.	NULL
Reyes	NULL
,	NULL
M.	NULL
S.	NULL
McGrath	NULL
,	NULL
B.	NULL
S.	NULL
Stein	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Engleman	NULL
.	NULL

1986	NULL
.	NULL

AIDS	NULL
retrovirus	NULL
induced	NULL
cytopathology	NULL
:	NULL
giant	NULL
cell	NULL
formation	NULL
and	NULL
involvement	NULL
of	NULL
CD4	NULL
antigen	NULL
.	NULL

Science	NULL
232	NULL
:	NULL
1123-1127	NULL
.	NULL

Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
S.	NULL
L.	NULL
Cross	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
D.	NULL
G.	NULL
Roman	NULL
,	NULL
M.	NULL
B.	NULL
Toledano	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1990	NULL
.	NULL

Delineation	NULL
of	NULL
an	NULL
enhancer-like	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:850-853	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:5490	NULL
.	NULL

Malek	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
R.	NULL
J.	NULL
Robb	NULL
,	NULL
and	NULL
E.	NULL
M.	NULL
Shevach	NULL
.	NULL

1983	NULL
.	NULL

Identification	NULL
and	NULL
initial	NULL
characterization	NULL
of	NULL
a	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
reactive	NULL
with	NULL
the	NULL
murine	NULL
interleukin	NULL
2	NULL
receptor-ligand	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80:5694-5698	NULL
.	NULL

Minty	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1986	NULL
.	NULL

Upstream	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
cardiac	NULL
actin	NULL
gene	NULL
that	NULL
modulate	NULL
its	NULL
transcription	NULL
in	NULL
muscle	NULL
cells	NULL
:	NULL
presence	NULL
of	NULL
an	NULL
evolutionarily	NULL
conserved	NULL
repeated	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

6:2125-2136	NULL
.	NULL

Mohun	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Garrett	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1987	NULL
.	NULL

Xenopus	NULL
cy-toskeletal	NULL
actin	NULL
and	NULL
human	NULL
c-fos	NULL
gene	NULL
promoters	NULL
share	NULL
a	NULL
conserved	NULL
protein-binding	NULL
site	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:667-673	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
C.-C.	NULL
Chang	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
M.	NULL
Salina	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
A.	NULL
T.	NULL
Maiolo	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
Chaganti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
lymphoma-associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
lyt-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-kB	NULL
p50	NULL
.	NULL

Cell	NULL
67:1075-1088	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.	NULL
C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kB	NULL
,	NULL
a	NULL
re	NULL
?	NULL

related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Norman	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Runswick	NULL
,	NULL
R.	NULL
Pollock	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
and	NULL
properties	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
SRF	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
55:989-1003	NULL
.	NULL

Palacios	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Steinmetz	NULL
.	NULL

1985	NULL
.	NULL

IL-3-dependent	NULL
mouse	NULL
clones	NULL
that	NULL
express	NULL
B-220	NULL
surface	NULL
antigen	NULL
,	NULL
contain	NULL
Ig	NULL
genes	NULL
in	NULL
germ-line	NULL
configuration	NULL
,	NULL
and	NULL
generate	NULL
B	NULL
lymphocytes	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
41:727-734	NULL
.	NULL

Pham-Dinh-Tuy	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
Tuil	NULL
,	NULL
F.	NULL
Schweighoffer	NULL
,	NULL
C.	NULL
Pinset	NULL
,	NULL
A.	NULL
Kahn	NULL
,	NULL
and	NULL
A.	NULL
Minty	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
CC.Ar.GG	NULL
box	NULL
:	NULL
a	NULL
protein-binding	NULL
site	NULL
common	NULL
to	NULL
transcription-regulatory	NULL
regions	NULL
of	NULL
the	NULL
cardiac	NULL
actin	NULL
c-fos	NULL
and	NULL
interleukin-2	NULL
receptor	NULL
genes	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

173:507-515	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1991	NULL
.	NULL

Silencing	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
kappa	NULL
gene	NULL
in	NULL
non-B	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1431-1437	NULL
.	NULL

Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
Lenardo	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Oligonucleotide	NULL
that	NULL
binds	NULL
nuclear	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
acts	NULL
as	NULL
a	NULL
lymphoid-specific	NULL
and	NULL
inducible	NULL
enhancer	NULL
element	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:1482-1486	NULL
.	NULL

Prywes	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1986	NULL
.	NULL

Inducible	NULL
binding	NULL
of	NULL
a	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
enhancer	NULL
.	NULL

Cell	NULL
47:777-784	NULL
.	NULL

Prywes	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1987	NULL
.	NULL

Purification	NULL
of	NULL
the	NULL
c-fos	NULL
enhancer-binding	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:3482-3489	NULL
.	NULL

Rivera	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Greenberg	NULL
.	NULL

1990	NULL
.	NULL

Growth	NULL
factor-induced	NULL
gene	NULL
expression	NULL
:	NULL
the	NULL
ups	NULL
and	NULL
downs	NULL
of	NULL
c-fos	NULL
regulation	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:751-758	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-92	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.	NULL
H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-trelated	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ryan	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
M.	NULL
Z.	NULL
Gilman	NULL
.	NULL

1989	NULL
.	NULL

Two	NULL
distinct	NULL
cellular	NULL
phosphoproteins	NULL
bind	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1785-1792	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
C.	NULL
Sisson	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1988	NULL
.	NULL

Transcriptional	NULL
autoregulation	NULL
of	NULL
the	NULL
proto-oncogene	NULL
fos	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
334:314-319	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-kB	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46:705-716	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
the	NULL
k	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
post-translational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47:921-928	NULL
.	NULL

Shaw	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
H.	NULL
Schroter	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
a	NULL
ternary	NULL
complex	NULL
to	NULL
form	NULL
over	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
correlates	NULL
with	NULL
serum	NULL
inducibility	NULL
of	NULL
the	NULL
human	NULL
c-fos	NULL
promoter	NULL
.	NULL

Cell	NULL
56:563-572	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1984	NULL
.	NULL

Interleukin	NULL
2	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

2:319-333	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

5:397-425	NULL
.	NULL

Staudt	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
H.	NULL
Singh	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
T.	NULL
Wirth	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
lymphoid-specific	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

IL-2R	NULL
«	NULL
e	NULL
GENE	NULL
REGULATION	NULL
2545	NULL
octamer	NULL
motif	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
323	NULL
:	NULL
640-643	NULL
.	NULL

Subramaniam	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
J.	NULL
Schmidt	NULL
,	NULL
C.	NULL
E.	NULL
Crutchfield	NULL
III	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Getz	NULL
.	NULL

1989	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
serum-responsive	NULL
enhancer	NULL
elements	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
340:64-66	NULL
.	NULL

Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992.	NULL
kB	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
promoter	NULL
by	NULL
human	NULL
c-re/	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067-4075	NULL
.	NULL

Tentori	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
J.	NULL
C.	NULL
Zuniga-Pfliicker	NULL
,	NULL
C.	NULL
Wing	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Kruisbeek	NULL
.	NULL

1988	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
the	NULL
interleukin	NULL
2-inter-leukin	NULL
2	NULL
receptor	NULL
pathway	NULL
in	NULL
thymocyte	NULL
maturation	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:1741-1747	NULL
.	NULL

Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
D.	NULL
G.	NULL
Roman	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Lin	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
same	NULL
target	NULL
sequences	NULL
are	NULL
differen-tially	NULL
important	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
in	NULL
two	NULL
distinct	NULL
T-cell	NULL
lines	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1830-1034	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1986	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
protein-binding	NULL
site	NULL
that	NULL
mediates	NULL
transcriptional	NULL
response	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
to	NULL
serum	NULL
factors	NULL
.	NULL

Cell	NULL
46:567-574	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Broder	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Waldmann	NULL
.	NULL

1981	NULL
.	NULL

A	NULL
monoclonal	NULL
antibody	NULL
(	NULL
anti-Tac	NULL
)	NULL
reactive	NULL
with	NULL
activated	NULL
and	NULL
functionally	NULL
mature	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

1	NULL
.	NULL

Production	NULL
of	NULL
anti-Tac	NULL
monoclonal	NULL
antibody	NULL
and	NULL
distribution	NULL
of	NULL
Tac	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

126	NULL
:	NULL
1393-1397	NULL
.	NULL

Waldmann	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
multi-subunit	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:875-911	NULL
.	NULL

Wilhelmsen	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
K.	NULL
Eggleton	NULL
,	NULL
and	NULL
H.	NULL
M.	NULL
Temin	NULL
.	NULL

1984	NULL
.	NULL

Nucleic	NULL
acid	NULL
sequences	NULL
of	NULL
the	NULL
oncogene	NULL
v-re	NULL
!	NULL

in	NULL
reticuloendo-theliosis	NULL
virus	NULL
strain	NULL
T	NULL
and	NULL
its	NULL
cellular	NULL
homolog	NULL
,	NULL
the	NULL
proto-ongogene	NULL
c-re/	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

52:172-182.	NULL
.	NULL

Zhu	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
Prywes	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
coactivator	NULL
that	NULL
increases	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
and	NULL
GAL4-VP16	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:5291-5295	NULL
.	NULL

Zuniga-Pflucker	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

